CA2477259A1 - System and method for pharmacy validation and inspection - Google Patents
System and method for pharmacy validation and inspection Download PDFInfo
- Publication number
- CA2477259A1 CA2477259A1 CA002477259A CA2477259A CA2477259A1 CA 2477259 A1 CA2477259 A1 CA 2477259A1 CA 002477259 A CA002477259 A CA 002477259A CA 2477259 A CA2477259 A CA 2477259A CA 2477259 A1 CA2477259 A1 CA 2477259A1
- Authority
- CA
- Canada
- Prior art keywords
- prescription
- pharmaceutical
- identifying information
- analysis unit
- dispensed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 51
- 238000007689 inspection Methods 0.000 title claims description 26
- 238000010200 validation analysis Methods 0.000 title description 15
- 238000004458 analytical method Methods 0.000 claims abstract description 41
- 150000001875 compounds Chemical class 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims description 56
- 239000000126 substance Substances 0.000 claims description 51
- 229940079593 drug Drugs 0.000 claims description 49
- 238000012795 verification Methods 0.000 claims description 45
- 230000000007 visual effect Effects 0.000 claims description 17
- 238000013500 data storage Methods 0.000 claims description 16
- 238000004611 spectroscopical analysis Methods 0.000 claims description 9
- 238000004497 NIR spectroscopy Methods 0.000 claims description 6
- 238000003384 imaging method Methods 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- 238000012015 optical character recognition Methods 0.000 claims description 4
- 230000003595 spectral effect Effects 0.000 claims description 4
- 238000004566 IR spectroscopy Methods 0.000 claims description 3
- 238000001069 Raman spectroscopy Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 238000012634 optical imaging Methods 0.000 claims description 2
- 230000000704 physical effect Effects 0.000 claims 2
- 238000005286 illumination Methods 0.000 claims 1
- 230000010354 integration Effects 0.000 claims 1
- 238000007405 data analysis Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000005429 filling process Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 239000007909 solid dosage form Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000036647 Medication errors Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003168 generic drug Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012306 spectroscopic technique Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
- G07F17/0092—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for assembling and dispensing of pharmaceutical articles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0264—Electrical interface; User interface
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/02—Details
- G01J3/0291—Housings; Spectrometer accessories; Spatial arrangement of elements, e.g. folded path arrangements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/88—Investigating the presence of flaws or contamination
- G01N21/95—Investigating the presence of flaws or contamination characterised by the material or shape of the object to be examined
- G01N21/9508—Capsules; Tablets
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/60—Type of objects
- G06V20/66—Trinkets, e.g. shirt buttons or jewellery items
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3563—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing solids; Preparation of samples therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3577—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing liquids, e.g. polluted water
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
Abstract
An apparatus for verifying the identity of a dispensed pharmaceutical comprises an analysis unit adapted to determine a property of the dispensed pharmaceutical, an input device adapted to receive predetermined identifying information corresponding to the dispensed pharmaceutical, and a comparison unit adapted to compare the determined property of the dispensed pharmaceutical with the predetermined identifying information. In addition, a method of verifying a prescription, wherein the prescription comprises a pharmaceutical compound, comprises associating the prescription with a unique identifier, storing the unique identifier, determining the identity of the pharmaceutical compound, and comparing the identity of the pharmaceutical compound with the unique identifier.
Description
SYSTEM AND METHOD FOR
PHARMACY VALIDATION AND INSPECTION
FIELD OF THE INVENTION
The present invention pertains to spectrometer and reflectance data analysis and more particularly to the validation and identification of packaged pharmaceuticals in a retail setting.
BACKGROUND OF THE INVENTION
There is an ongoing and predicted long-term shortage of licensed pharmacists.
Due to the increasing age of the population and the ever-increasing number of prescription medicines available, the demand for prescription drugs is growing at rate that will far exceed the capacity and numbers of licensed pharmacists.
According to the National Association of Chain Drug Stores, the number of prescriptions filled between 2000 and 2005 will increase by 41 %, while the number of retail pharmacists will only increase by 4.5%. The net impact of this imbalance is that pharmacists are increasingly spending more time doing clerical and administrative tasks such as verifying filled prescriptions and checking data entry done by pharmacy technicians.
Since the capacity of any one pharmacist is fixed, the output of a pharmacy has become constrained. Consequently, the labor and total cost per prescription continues to rise.
The December 2000 Department of Health and Human Services Report to Congress titled "The Pharmacist Workforce: A Study of the Supply and Demand for Pharmacists", which is hereby incorporated by reference into the present application, provides an overview of the above problem.
Due to these increased demands on a pharmacist's time, and the resulting increased reliance on technicians and other non-professional staff to fill prescriptions, there is an increased chance for prescription error. While these errors may take many forms, the likelihood of a dangerous or life threatening "adverse drug event"
increases proportionally with the increased chance of prescription fill error. Several studies have shown that prescription error rates are consistently in the 2% to 7% range, with a 4%
error rate often cited as a reliable average. The number of deaths due to medication errors is estimated to exceed 7000 per year in the United States alone. This number does not include non-fatal conditions from drugs that also result in some form of trauma or injury. The resulting litigation costs associated with these prescription fill errors has also dramatically increased. Available information shows that settlements from such lawsuits average $500,000 per incident. A known study on this subject is the 1999 Institute of Medicine Report: "To Err is Human: Building a Safer Heath System", the details of which are hereby incorporated by reference into the present application.
Existing pharmacy filling systems and procedures still require a human operator, whether that operator is a technician or a licensed pharmacist, to validate visually whether the drug that is delivered to the customer is correct. Thus, the human factor contributes to the majority of prescription fill errors. Existing visual verification techniques rely on comparing an electronic image of the prescribed medication, i.e. a picture of the prescribed medication retrieved from a data library, with the actual medication that is dispensed for the patient. Other systems and procedures rely on comparing the dispensed medication with that in the original manufacturer's supply container, or comparing an electronic image of the filled prescription with an electronic image of the prescribed medication retrieved from a data library. Each of these existing verification systems present similar problems.
First, these known verification methods assume that all drugs are visually distinct. This assumption causes many problems because many drugs are not, in fact, visually distinct and, in other cases, the visual differences between drugs is very subtle.
For instance, manufacturers are rapidly running out of unique shapes, colors and sizes for their solid dosage form products. To further complicate the problem, generic drug manufactures are using shapes, colors, and sizes that are different than that of the original manufacturer.
Second, even though some known systems may utilize a National Drug Code (NDC) bar code to verify that the supply bottle being accessed corresponds correctly to the patient's prescription, a fraction of filled prescriptions that are never picked up are returned to the supply shelves for reuse in later prescriptions. These reused bottles will not, therefore, have a manufacturer's bar code on them. It is, therefore, impossible to incorporate such validation schemes for these unused prescriptions.
Furthermore, in these circumstances, a supply bottle is not available for a visual comparison with the filled prescription.
PHARMACY VALIDATION AND INSPECTION
FIELD OF THE INVENTION
The present invention pertains to spectrometer and reflectance data analysis and more particularly to the validation and identification of packaged pharmaceuticals in a retail setting.
BACKGROUND OF THE INVENTION
There is an ongoing and predicted long-term shortage of licensed pharmacists.
Due to the increasing age of the population and the ever-increasing number of prescription medicines available, the demand for prescription drugs is growing at rate that will far exceed the capacity and numbers of licensed pharmacists.
According to the National Association of Chain Drug Stores, the number of prescriptions filled between 2000 and 2005 will increase by 41 %, while the number of retail pharmacists will only increase by 4.5%. The net impact of this imbalance is that pharmacists are increasingly spending more time doing clerical and administrative tasks such as verifying filled prescriptions and checking data entry done by pharmacy technicians.
Since the capacity of any one pharmacist is fixed, the output of a pharmacy has become constrained. Consequently, the labor and total cost per prescription continues to rise.
The December 2000 Department of Health and Human Services Report to Congress titled "The Pharmacist Workforce: A Study of the Supply and Demand for Pharmacists", which is hereby incorporated by reference into the present application, provides an overview of the above problem.
Due to these increased demands on a pharmacist's time, and the resulting increased reliance on technicians and other non-professional staff to fill prescriptions, there is an increased chance for prescription error. While these errors may take many forms, the likelihood of a dangerous or life threatening "adverse drug event"
increases proportionally with the increased chance of prescription fill error. Several studies have shown that prescription error rates are consistently in the 2% to 7% range, with a 4%
error rate often cited as a reliable average. The number of deaths due to medication errors is estimated to exceed 7000 per year in the United States alone. This number does not include non-fatal conditions from drugs that also result in some form of trauma or injury. The resulting litigation costs associated with these prescription fill errors has also dramatically increased. Available information shows that settlements from such lawsuits average $500,000 per incident. A known study on this subject is the 1999 Institute of Medicine Report: "To Err is Human: Building a Safer Heath System", the details of which are hereby incorporated by reference into the present application.
Existing pharmacy filling systems and procedures still require a human operator, whether that operator is a technician or a licensed pharmacist, to validate visually whether the drug that is delivered to the customer is correct. Thus, the human factor contributes to the majority of prescription fill errors. Existing visual verification techniques rely on comparing an electronic image of the prescribed medication, i.e. a picture of the prescribed medication retrieved from a data library, with the actual medication that is dispensed for the patient. Other systems and procedures rely on comparing the dispensed medication with that in the original manufacturer's supply container, or comparing an electronic image of the filled prescription with an electronic image of the prescribed medication retrieved from a data library. Each of these existing verification systems present similar problems.
First, these known verification methods assume that all drugs are visually distinct. This assumption causes many problems because many drugs are not, in fact, visually distinct and, in other cases, the visual differences between drugs is very subtle.
For instance, manufacturers are rapidly running out of unique shapes, colors and sizes for their solid dosage form products. To further complicate the problem, generic drug manufactures are using shapes, colors, and sizes that are different than that of the original manufacturer.
Second, even though some known systems may utilize a National Drug Code (NDC) bar code to verify that the supply bottle being accessed corresponds correctly to the patient's prescription, a fraction of filled prescriptions that are never picked up are returned to the supply shelves for reuse in later prescriptions. These reused bottles will not, therefore, have a manufacturer's bar code on them. It is, therefore, impossible to incorporate such validation schemes for these unused prescriptions.
Furthermore, in these circumstances, a supply bottle is not available for a visual comparison with the filled prescription.
Finally, each of these known manual verification and validation techniques requires that the pharmacist spend a significant portion of his day performing these administrative or clerical tasks and allows less time for patient consultation and other professional pharmacist activities. This fact in itself is considered one of the leading reasons for the decline in graduation rate of professional pharmacists. The ability to allow the pharmacist to focus more on patient counseling rather than clerical and administrative duties is widely seen as an important promotional effort to meet the increasing demand for professionally trained pharmacists. Similarly, personal service by a pharmacist is cited in the 2001 Chain Pharmacy Industry Profile as one of the main reasons that a customer will choose any particular pharmacy.
Solid dosage pharmaceuticals (e.g. pills, tablets, and capsules) each have a unique chemical composition associated with them. This is often referred to as a chemical signature or fingerprint. Pharmaceuticals with varying dosage levels of the same active ingredient may have unique chemical signatures as well. Even slight variations in the active ingredient will produce a unique chemical signature.
In that regard, most pharmaceuticals can be identified accurately by the use of some form of chemical analysis. This same methodology may be applied to other forms of medication (e.g. liquids, creams, and powders).
While there are many forms of chemical analysis, Near-Infrared (NIR) spectroscopy is one of the most rapidly growing methodologies in use for product analysis and quality control. For instance, NIR spectroscopy is being increasingly used as an inspection method during the packaging process of pharmaceuticals or food products. More and more often, this technique is augmenting or even replacing previously used vision inspection systems. For example, a system that utilizes a combined visible and NIR spectroscopy inspection system can be used to inspect a pharmaceutical product for, among other things, chemical composition, color, and dosage level.
Particularly with solid dosage pharmaceutical products, while a group or package of products may look identical in the visible portion of the spectrum each product may have a unique chemical signature in the near-infrared wavelength range (800-2500 nm). Details of packaging and inspection systems that utilize NIR as an inspection technique can be found in U.S. Patent Applications Nos. 10/023,302, 10/023,395, and 10/023,396 filed on December 20, 2001 and U.S. Patent Application No. 10/068,623 filed on February 5, 2002, the details of which are hereby incorporated by reference into the present application.
What is unique about these NIR spectrographic inspection and validation systems is the completely "hands-off ' approach that can be utilized, and the reduced need for operator interaction in validating the composition of packaged and filled pharmaceuticals. What is needed, therefore, is a system that can utilize the unique chemical signatures of known pharmaceuticals to validate the accuracy of the filled prescription through an NIR spectrographic or other chemical analysis technique.
More particularly, what is needed is a system that allows the replacement of the manual verification techniques that most pharmacies rely on today, thereby allowing verification and validation steps to be performed automatically and consequently requiring less trained and less expensive supervision. What is also needed is a system that will account for the predicted added prescription throughput and reduced supply of trained pharmacists that the pharmacy industry will face in the coming years.
Finally, what is needed is a system that will help reduce per prescription costs, reduce error rates in filling prescriptions, increase pharmacist productivity, reduce the time to complete a prescription order and allow pharmacists to spend more time with their customers and engaged in other professional responsibilities.
2p SUMMARY OF THE INVENTION
In one aspect, an apparatus for verifying the identity of a dispensed pharmaceutical comprises an analysis unit adapted to determine a property of the dispensed pharmaceutical, an input device adapted to receive predetermined identifying information corresponding to the dispensed pharmaceutical, and a comparison unit adapted to compare the determined property of the dispensed pharmaceutical with the predetermined identifying information.
In another aspect, a method of verifying a prescription, wherein the prescription comprises a pharmaceutical compound, comprises associating the prescription with a unique identifier, storing the unique identifier, determining the identity of the pharmaceutical compound, and comparing the identity of the pharmaceutical compound with the unique identifier.
In another aspect, a method of adapting an existing pharmacy information system to perform verification of a dispensed pharmaceutical comprises providing an analysis unit adapted to measure a property of the dispensed pharmaceutical, providing an input device adapted to receive predetermined identifying information corresponding to the dispensed pharmaceutical, and providing a comparison unit adapted to compare the measured property of the dispensed pharmaceutical with the , predetermined identifying information.
In another aspect, an inspection system for verifying the contents of a filled prescription, comprises a spectrometer adapted to determine the spectral signature of the contents of the filled prescription, a scanner adapted to receive identifying information corresponding to the filled prescription, a data storage device coupled to the scanner and adapted to store the identifying information corresponding to the filled prescription, wherein the data storage device comprises a plurality of data items, each of the plurality of data items corresponding to a known prescription pharmaceutical spectral signature.
In another aspect, a method of filling a prescription, comprises receiving a prescription request, entering the prescription request into an information system, dispensing the prescription from a supply source into a customer container, applying an identification label on the customer container, wherein the identification label contains identifying information corresponding to the prescription, storing the identifying information corresponding to the prescription, determining the identity of the prescription, and comparing the identity of the prescription to the identifying information.
As will become apparent to those skilled in the art, numerous other embodiments and aspects will become evident hereinafter from the following descriptions and claims.
BRIEF DESCRIPTION OF THE DRAWINGS
The drawings illustrate both the design and utility of the preferred embodiments of the present invention, wherein:
Figure 1 is a flow chart depicting a known pharmacy filling and verification process;
Figure 2 is a flow chart showing a pharmacy filling and verification process in accordance with an aspect of the present invention;
Figure 3 is a detailed flow chart of the chemical verification process in accordance with an aspect of the present invention;
Figure 4 is an embodiment of a chemical analysis and verification system in accordance with an aspect of the present invention;
Figure 5 is a detailed diagram of the main housing of a chemical analysis and verification system in accordance with an aspect of the present invention;
Figure 6 is a detailed diagram of the spectrometer and telescope assembly of a chemical analysis and verification system in accordance with an aspect of the present invention; and Figure 7 is a top view of a filled prescription vial as it is seen by a chemical analysis and verification system in accordance with an aspect of the present invention:
DETAILED DESCRIPTION
Approximately 90% of the most commonly prescribed and dispensed solid-dosage pharmaceuticals can be identified through an NIR or other spectroscopic technique with 100% accuracy. By comparing the "chemical signature" of a dispensed or filled prescription to an electronic database of known formulations, there can be near 100% assurance that a dispensed drug is correct in both type and concentration.
Figure 1 shows a workflow and validation process 100 that is typical for known pharmacies and their associated prescription filling procedures. While this example is based on the filling of a solid dosage prescription, similar procedures are utilized for other dosage forms. In the workflow 100 shown in Figure 1, 100% of the drugs stocked by a pharmacy and filled for a patient follow the same path. In the flow diagram 100, the bracketed text to the left indicates the pharmacy personnel that would typically perform the corresponding task. To begin the prescription filling process, a customer drops off or calls in an order at 110. The order consists of one or more new or refill prescriptions. The prescriptions) are entered into the pharmacy's information system at 120. As indicated, step 120 is typically performed by a technician or other administrative staff, although it may be performed by a pharmacist as well.
After the order has been entered into the pharmacy information system, a pharmacist verifies that the prescription has been entered into the pharmacy information system correctly at 130. Step 130 is typically performed by comparing the information entered into the pharmacy information system with the information contained on the written prescription. Some systems actually scan the written prescription into the pharmacy information systems so that a side by side comparison can be made on a computer screen of an image of the written prescription prepared by a physician and the data entered by the technician at step 120. Once the entered prescription is verified at 130, the filling process begins. A technician fills the prescription at 140. Some known systems utilize bar codes to ensure that the correct supply bottle has been selected by the technician. All manufacturer supply bottles include a bar coded identification number that contains information unique to the product and manufacturer. Other tasks that are typically performed at step 140 include assigning a tote (customer container to hold multiple prescriptions for the same customer) to the order, scanning the supply bottle, counting tablets and filling the vials, printing labels and applying the label to the vial, and closing the vial and placing it in the assigned tote. Further details of these visual pharmacy inspection and verification systems can be found in U.S.
Patent Nos.
5,597,995, 6,176,392, and 6,202,923, the details of which are hereby incorporated by reference into the present application.
After the order has been filed at 140, the pharmacist must verify the contents and accuracy of the filled order at 150. Since the pharmacist is ultimately responsible for the accuracy,of the filled order, this task is usually not assigned to a technician or other clerical employee. While the verification step 150 can be performed in several different ways, all existing pharmacy systems utilize a visual verification process that is carried out by a professional pharmacist. Figure 1 includes several examples (150-1, 150-2, and 150-3) of how this visual verification process is normally handled.
At 150-1 a pharmacist compares the contents of the filled customer vial with the supply bottle that was used to fill the prescription. In the case of 150-1, the supply bottle is often left in the customer tote with the filled vial for the pharmacist to use in verifying the vial's contents. This is, in effect, a tablet-to-tablet comparison.
Alternately, at 150-2 the pharmacist compares the contents of the filled vial to an image of the prescribed drug that is retrieved from a database displayed on a computer monitor for the pharmacist to view. This is a tablet-to-image comparison.
Alternately, at 150-3 the pharmacist compares an electronic image taken of the filled vials with a database image of the same prescribed drug. This is an image-to-image comparison.
Certain automated prescription filling systems utilize these image-based verification schemes by taking an image of the filled vial before it is released to the pharmacist for verification. Finally, at 160 the order is placed with the appropriate paperwork in a pickup area for the customer to receive the prescription.
As explained above, these known pharmacy systems all suffer from the same general problems in that they rely on a visual verification performed by a human operator to validate that the prescription has been properly filled. The result is that a significant number of prescriptions are incorrectly filled. Additionally, the pharmacist, who is ultimately responsible for the accuracy of the filled prescription, spends a significant portion of his or her day performing these verifications. These and other known pharmacy inspection systems are more fully described in U.S. Patent Nos.
5,597,995, 6,176,392, and 6,202,923, the details of which have previously been incorporated by reference into the present application.
In accordance with an aspect of the present invention, an inspection system is provided that preferably replaces the visual verification steps associated with traditional and known pharmacy systems. Alternatively, an inspection system constructed in accordance with the present invention can augment existing visual verification systems.
In addition, an inspection system constructed in accordance with the present invention can preferably be adapted for use with an existing pharmacy information system, or can be utilized as a stand alone and portable unit.
Figure 2 illustrates a work flow 200 associated with one aspect of a pharmacy inspection and validation system constructed in accordance with the present invention.
While this example is based on the filling of a solid dosage prescription, similar procedures may be utilized for other dosage forms. A customer drops off or otherwise communicates a prescription to the pharmacy at 210. At 220, the customer's prescription is input into the pharmacy's information system or, if the prescription is for a refill, the prescription is recalled from the pharmacy's information system.
Step 220, as in the system of Figure l, is typically performed by a pharmacy technician, rather than by a licensed pharmacist. At 230, a pharmacist performs a verification that the customer prescription is properly entered into the pharmacy information system. Step 230 is typically performed by comparing the information entered into the pharmacy information system with the information contained on the written prescription.
As in the system of Figure 1, some systems actually scan the written prescription into the pharmacy information system so that a side by side comparison can be made on a computer screen of an image of the written prescription prepared by a physician and the data entered by the technician at step 220. At 240, after the entered prescription is verified by the pharmacist, it is released for filling (typically done by a technician).
The technician then fills the customer vial and applies the prescription label, including a bar code linked to both the prescription number and the dispensed drug's unique NDC
code, to the vial. Preferably, the bar code on the prescription label includes a prescription number that is unique to that specific prescription fill. For example, a refill prescription will get a new prescription number and not one identical to the original prescription. This accounts for the situation where two prescriptions for the same drug are being filled at the same time and allows a unique identifier to be associated with the prescription in addition to the manufacturer's NDC code.
At this point, the filled vial is inserted into a chemical analysis system.
The chemical analysis and validation system is referred to herein as the RxSpecTM
system.
At 245, the bar code label on the filled customer prescription vial is read into the RxSpecTM system. The steps performed by the RxSpecTM system, and in general, the pharmacy chemical analysis and validation system, are generally shown in Figure 2 within the dashed lines represented by reference number 300. Preferably, the RxSpecTM system utilizes visible (Vis) and near-infrared (NIR) spectroscopy to analyze and identify the contents of the filled prescription vial, however, it is contemplated that any number of other methods or variations of NIR spectroscopy can be utilized in a pharmacy system constructed in accordance with the present invention. For example, various forms of optical spectroscopy, ultra-violet & visible (UV-Vis), Ultra-violet/visible/near infrared (UV-Vis-NIR), infrared, or Raman spectroscopy may be utilized in a chemical analysis and verification system constructed in accordance with the present invention. Additionally, optical imaging technology can also be integrated into a chemical analysis and verification system constructed in accordance with the present invention, such as systems that are adapted to perform optical character recognition (OCR), color analysis, or other physical (rather than chemical) property analysis and identification.
At 310, the RxSpecTM system compares the NDC derived from the bar code scanned from the label on the customer prescription vial, to a database of drugs that the RxSpecTM has been formatted or otherwise calibrated to chemically identify. At this point, no chemical identification has taken place, rather the RxSpecTM system is comparing the name and dosage of the drug associated with the customer's prescription with a preloaded database of drugs that the RxSpecTM system has been calibrated to analyze. The database also contains a representation of the unique chemical signatures associated with each of these calibrated drugs. It is contemplated that this database of calibrated drugs will be periodically updated to reflect new drugs that come on the market as well as existing drugs that are calibrated to be recognized by the RxSpecTM
system. If the customer's prescription is contained in the RxSpecTM database, then, at 320, the RxSpecTM system performs a chemical identification on the actual tablets, or capsules that are contained in the customer's prescription vial. At 320 the RxSpecTM
system scans the items in the filled vial and measures the chemical signature of the items. This actual chemical signature is then matched to a particular drug and dosage level from the database of calibrated drugs. This information is then compared at 330 to the prescription information taken from the bar code label on the customer's filled prescription vial, which has been previously stored by the RxSpecTM system. If the results from the RxSpecTM system match the information from the bar code on the customer's filled prescription vial, the RxSpecTM system signals that the filled prescription has been verified and the technician then closes the filled vial, finalizes the prescription, and places it into a tote for customer pickup at 340. The inspection and validation steps associated with the RxSpecTM system are automatic and can therefore be easily performed by a technician rather than a pharmacist.
If at step 310 it is determined that the customer's prescription is not contained in the RxSpecTM database, and therefore not amenable to chemical verification, the RxSpecTM system signals the technician that it can not chemically verify the customer's prescription and that another form of verification is necessary. At 350, an alternate verification means is then employed, such as one of the visual verification techniques previously described in connection with Figure 1. After the customer's filled prescription has been verified the prescription is finalized, bagged, and placed in a tote for customer pickup at 360.
From experimental results, it has been determined that in the process flow of Figure 2, approximately 90% of the drugs will be able to be recognized by the RxSpecTM system and will therefore be able to be automatically verified and validated by chemical analysis and comparison to the prescription's bar code information. Those drugs that are not recognized by the RxSpecTM system will need to be visually verified as described above or by a similar method. In practice, verifying a prescription using the RxSpecTM system is approximately 5 times faster than using a manual verification method, such as visual verification. For example, in efficiently run pharmacies, it takes approximately 25 seconds to visually verify a prescription. Using the RxSpecTM
system has been demonstrated to take approximately 5 seconds. Furthermore, the RxSpecTM system can be run by a technician since the verification process is entirely automatic. Visual verifications, since they are subject to user error, are typically performed by a pharmacist. Large retail pharmacies filling as many as 300 prescription per day and utilizing a verification system constructed in accordance with the present invention will realize a net result of the pharmacist having approximately 1.7 hours of available time to perform other tasks such as patient consultation or filling additional prescriptions. The RxSpecTM system directly identifies the actual drug contained in the prescription vial and compares it to a pre-stored library of drug signature data. For those drugs that are recognized by the RxSpecTM system, this verification is accomplished with virtually 100% accuracy. Other benefits are also realized by implementing the inspection and validation process of Figure 2. For instance, pharmacist job satisfaction and morale will likely increase as a result of reduced stress and less time performing visual verification tasks; there will be faster prescription throughput time for those drugs verified by the RxSpecTM system; there is a reduction in overtime wages; and the use of such an automated verification systems may be recognized as evidence of proper prescription filling in the context of litigation.
Figure 3 shows a detailed flow diagram 400 of a portion of the RxSpecTM
system, and more particularly, one embodiment of the automated chemical identification and verification process. At 410, a technician scans the bar code on a prescription vial's label using a scanner attached to the RxSpecTM system.
Preferably, the scanner presents an audible tone or visual indicator letting the user know that the label has been scanned successfully. The data obtained from the bar code is sent to and stored on a data storage device such as a magnetic disk drive or a network server. It is contemplated that various computer hardware platforms may be utilized in such a system such as PCDOS, WINDOWS, UNIX, LINUX, etc. Additionally, the hardware platform may be part of the pharmacy's existing information system.
After the data from the bar code label has been stored, the RxSpecTM system determines at 420 whether the drug, as represented by the data from the scanned bar code label on the customer's prescription vial, is in the RxSpecTM data library, and thus recognized by the RxSpecTM system. The RxSpecTM data library, is preferably a stored database of drug formulations, dosage signatures, and their associated product names, manufacturers and other identifying information that is recognized by and calibrated to the RxSpecTM system. If the drug in the filled prescription vial is not recognized by the RxSpecTM system, then at 430, the data server sends a message to the RxSpecTM
system and the technician is notified not to proceed with a chemical scan of the filled prescription through the RxSpecTM system. The technician and the general pharmacy information system are notified that this particular drug must follow a standard manual/visual verification routine as previously described in conjunction with Figure 1.
If the drug in the filled prescription vial is recognized by the RxSpecTM
system, then at 440, the RxSpecTM system indicates to the technician that he can proceed with the chemical scan. The technician then places the filled prescription vial into the RxSpecTM system, the drug, while still in the prescription vial, is scanned and the resulting chemical signature data is sent to the server or existing pharmacy information system. At 450, the RxSpecTM system compares the data obtained from the prescription vial bar code to the data obtained from the chemical scan and determines whether there is a match or whether there is some form of user error such as the prescription vial being improperly aligned in the RxSpecTM system. If there is a user error detected, the RxSpecTM system alerts the technician at 460 and allows the technician to rescan the drug. If the RxSpecTM system determines that the chemical scan of the drug and the data from the prescription vial bar code are a match, the RxSpecTM system at 470 sends a message to the technician that the drug has passed the chemical inspection and validation and that the prescription vial can be capped and the prescription completed. In this case, visual inspection is not necessary, although, if desired, the pharmacist can choose to also visually verify the filled prescription. If the RxSpecTM system determines that the chemical scan of the drug and the data from the prescription vial bar code are not a match, the RxSpecTM system at 480 sends a message to the technician that the drug has failed the chemical inspection and validation process.
A further message may also be sent to the technician indicating that either visual verification must be completed or that the pharmacist must otherwise intervene in the prescription filling process.
Figure 4 shows one embodiment of an RxSpecTM system 500 constructed in accordance with an aspect of the present invention. The RxSpecTM system 500 can be formatted to function either as a stand alone unit or to integrate into an existing pharmacy information system. Line 505 in Figure 4 defines an example of how the stand alone portion of the RxSpecTM system could be incorporated into an existing pharmacy information system. The portion above the line 505 would be located in the actual pharmacy within easy access of the pharmacist, while the portion below line 505 represents an existing pharmacy information system such as a network server or other information system platform. As a stand alone unit, the RxSpecTM system would preferably be linked to a PC based computer or portable computer system.
The RxSpecTM system 500 includes a main housing unit 510 that contains the chemical analysis hardware and associated electronics. Preferably, the chemical analysis hardware is an Vis-NIR-based spectrometer system adapted for use in the RxSpecTM system. However, other chemical analysis systems are contemplated by the present invention such as various forms of optical spectroscopy, ultra-violet & visible (UV-Vis), Ultra-violet/visible/near infrared (UV-Vis-N1R), infrared, or Raman spectroscopy. It is also envisioned that digital imagery could be used to automatically derive information on the size, shape, and color of solid dosage forms. The main housing 510 includes a local display unit 512 that provides a user with information such as pass/fail results, system status, power availability, and various other functional indicators of the RxSpecTM system 500. The main housing 510 is positioned on a mounting bracket 514 so that an imaging aperture or entrance slit 515 of the main housing faces a sample plate 516. The sample plate 516 is adapted to receive a sample, such as a prescription vial 532, so that the imaging aperture 515 substantially aligns with the vial 534. Preferably a guide 538 is incorporated into the sample plate 516 to easily and consistently align the vial 532 under the imaging aperture 515.
The main housing 510 is connected to a power source 519 through a cable 518 and connector 520. The main housing 510 of the RxSpecTM system preferably receives data through two separate connections. First, the main housing 510 receives data from data storage and analysis unit 550 through cable 522 and connector 524.
Second, the main housing 510 receives data from scanner 540 through cable 526 and connector 528.
The data storage and analysis unit, can, as described above, be either a network based system connected to the main housing 510 through a 10/100 Baser Ethernet connection, or it can be a local system, such as a PC or laptop computer connected through a serial or USB port. Various other connection schemes are also contemplated.
In operation, data obtained through the scanner 540 from a label 534 applied to the vial 532 is compared to data obtained by chemically identifying the actual product contained in the vial 532. Preferably the label 534 is a bar code containing the unique prescription number. In one embodiment a spectrometer-based system shines a light beam 536 at the product in the vial 532 and acquires the chemical signature data of the product. The chemical signature data and the data obtained from the bar code label 534 are both sent back to the data storage and analysis unit 550. The data storage and analysis unit 550 first queries the prescription database to determine the NDC
of the drug used to fill the prescription currently being verified. The data storage and analysis unit 550 preferably contains a database of chemical fingerprints corresponding to the drugs available in the pharmacy. The database also includes the corresponding NDC, manufacture name, drug name, and other identifying information about the available drugs. The data storage and analysis unit 550 is also adapted to run comparison software and other algorithms that automatically compare the NDC determined from the bar code label 534 and the signature of the analyzed product 534 contained in the vial 532. A message is sent from the data storage and analysis unit S50 back to the RxSpecTM system's main housing 510 alerting the user whether the prescription being verified has passed or failed the verification process.
The data storage and analysis unit 550 can take various forms as briefly described above. First, it can be part of an existing pharmacy information system, such as a UNIX based server where the RxSpecTM signature library and comparison software reside on a storage area within the existing server unit. Second, the data storage and analysis unit 550 can be a stand alone computer unit such as a PC based system or laptop computer system. In this case, the RxSpecTM chemical signature library and comparison software reside on a storage area within the stand alone unit. In that regard, the RxSpecTM system would be more conducive to portability and could be utilized in other sites than just pharmacies such as emergency rooms and ambulance environments.
Figure 5 shows a schematic detail of the housing 510 and, more particularly, one embodiment of its internal construction and interrelation between its various components. The housing 510 as shown in Figure 5, is configured for use with a spectrometer based analysis system, and more particularly, a Vis-NIR
spectrometer system, however, it is contemplated that other types of non-invasive chemical and/or physical analysis systems can be incorporated into systems constructed in accordance with the present invention and as described above. The housing 510 generally contains six main components or modules. An alphanumeric display 512, a main electronics board 600, a focal plane board 630, a spectrograph assembly 640, a light source 670 and a telescope 680. The arrows in Figure 5 show one embodiment of the inter-relationship between the different components of the main housing 510.
The alphanumeric display 510 is adapted to display a number of different information parameters pertaining to the status of the RxSpecTM system such as power on status, pass or fail results of an ongoing chemical screen or identification, etc. The main electronics board 600 includes the following modules and functions: a power supply 602, light regulation 604, data collection 606, microprocessor 608, ethernet interface 610, scanner or bar code interface 612, and a mechanism control 614.
The main electronics board 600 also preferably includes the connection ports for the power supply, the ethernet connection and a serial port for the scanner interface.
The focal plane board 630 includes the spectrometer detector and associated electronics 632. The detector 632 interprets the reflected light data from a sample being analyzed and transmits it back to the main electronics board for interpretation.
The detector and electronics 632 can be one of many known in the spectroscopy art. In other embodiments, the focal plane board may include an exit and~entrance slit for the spectrometer, a cut-on filter, a light source mirror, and mounts for each of the slits and filter.
The spectrograph assembly 640 includes a detector 642, grating 644, lens 646, encoder 648, motor 650, shutter 652, and scanner mechanism 654. The light source 670 is preferably a white light that provides a broad range of wavelengths and is adapted to illuminate a sample 700 that is being analyzed. The light source 670 may be integrated with the telescope assembly 680. The telescope assembly 680 includes slit imaging optics 682, a white reference mechanism 684, a beam rotate mechanism 686, and an auto-focus mechanism 688.
Figure 6 shows one embodiment of elements from the spectrograph assembly 640 and telescope 680 from Figure 5, and more particularly, the relationship between the telescope and focusing elements to the spectrometer. It is contemplated that numerous other embodiments of the spectrometer and telescope can be incorporated into a pharmacy inspection system in accordance with the present invention, many of which are known to those of skill in the art of spectroscopy and chemical analysis. In Figure 6, the combined spectrometer and telescope assembly includes a spectrometer 810 having an entrance slit 812, a pair of lenses 820 and 825, a collimated light source 830 a mirror 832, and a rotating beam steering element 840. The telescope assembly is generally referred to as 680. The dashed line 850 represents those elements of the telescope assembly that are adapted to move up and down in order to adjust the focal point of the system. Correct focus of the system is obtained by automatically adjusting the position of the telescope focusing elements 850 to a position that provides the maximum signal as measured by the spectrometer 810. The product being inspected 700 sits in the vial 532 and is positioned under the telescope assembly 680.
The rotating beam steering element 840 is adapted to take a series of measurements of the product 700. Preferably, the measurements are collected in a circular or ring shaped pattern to ensure consistency of the contents of the vial.
Figure 7 shows an image of the vial 532 filled with a product 700 that is being inspected. The image in Figure 7 is how the vial 532 and product 700 would appear to the telescope assembly, i.e. looking down into the filled vial. Ring 860 represents the scanning path produced by the rotating beam steering element 840 and points represent a series of locations measured by the RxSpecTM. Other sampling patterns or analysis algorithms may be incorporated into the spectrometer system in accordance with the present invention.
Although the present invention has been described and illustrated in the above description and drawings, it is understood that this description is by example only and that numerous changes and modifications can be made by those skilled in the art without departing from the true spirit and scope of the invention. The invention, therefore, is not to be restricted, except by the following claims and their equivalents.
Solid dosage pharmaceuticals (e.g. pills, tablets, and capsules) each have a unique chemical composition associated with them. This is often referred to as a chemical signature or fingerprint. Pharmaceuticals with varying dosage levels of the same active ingredient may have unique chemical signatures as well. Even slight variations in the active ingredient will produce a unique chemical signature.
In that regard, most pharmaceuticals can be identified accurately by the use of some form of chemical analysis. This same methodology may be applied to other forms of medication (e.g. liquids, creams, and powders).
While there are many forms of chemical analysis, Near-Infrared (NIR) spectroscopy is one of the most rapidly growing methodologies in use for product analysis and quality control. For instance, NIR spectroscopy is being increasingly used as an inspection method during the packaging process of pharmaceuticals or food products. More and more often, this technique is augmenting or even replacing previously used vision inspection systems. For example, a system that utilizes a combined visible and NIR spectroscopy inspection system can be used to inspect a pharmaceutical product for, among other things, chemical composition, color, and dosage level.
Particularly with solid dosage pharmaceutical products, while a group or package of products may look identical in the visible portion of the spectrum each product may have a unique chemical signature in the near-infrared wavelength range (800-2500 nm). Details of packaging and inspection systems that utilize NIR as an inspection technique can be found in U.S. Patent Applications Nos. 10/023,302, 10/023,395, and 10/023,396 filed on December 20, 2001 and U.S. Patent Application No. 10/068,623 filed on February 5, 2002, the details of which are hereby incorporated by reference into the present application.
What is unique about these NIR spectrographic inspection and validation systems is the completely "hands-off ' approach that can be utilized, and the reduced need for operator interaction in validating the composition of packaged and filled pharmaceuticals. What is needed, therefore, is a system that can utilize the unique chemical signatures of known pharmaceuticals to validate the accuracy of the filled prescription through an NIR spectrographic or other chemical analysis technique.
More particularly, what is needed is a system that allows the replacement of the manual verification techniques that most pharmacies rely on today, thereby allowing verification and validation steps to be performed automatically and consequently requiring less trained and less expensive supervision. What is also needed is a system that will account for the predicted added prescription throughput and reduced supply of trained pharmacists that the pharmacy industry will face in the coming years.
Finally, what is needed is a system that will help reduce per prescription costs, reduce error rates in filling prescriptions, increase pharmacist productivity, reduce the time to complete a prescription order and allow pharmacists to spend more time with their customers and engaged in other professional responsibilities.
2p SUMMARY OF THE INVENTION
In one aspect, an apparatus for verifying the identity of a dispensed pharmaceutical comprises an analysis unit adapted to determine a property of the dispensed pharmaceutical, an input device adapted to receive predetermined identifying information corresponding to the dispensed pharmaceutical, and a comparison unit adapted to compare the determined property of the dispensed pharmaceutical with the predetermined identifying information.
In another aspect, a method of verifying a prescription, wherein the prescription comprises a pharmaceutical compound, comprises associating the prescription with a unique identifier, storing the unique identifier, determining the identity of the pharmaceutical compound, and comparing the identity of the pharmaceutical compound with the unique identifier.
In another aspect, a method of adapting an existing pharmacy information system to perform verification of a dispensed pharmaceutical comprises providing an analysis unit adapted to measure a property of the dispensed pharmaceutical, providing an input device adapted to receive predetermined identifying information corresponding to the dispensed pharmaceutical, and providing a comparison unit adapted to compare the measured property of the dispensed pharmaceutical with the , predetermined identifying information.
In another aspect, an inspection system for verifying the contents of a filled prescription, comprises a spectrometer adapted to determine the spectral signature of the contents of the filled prescription, a scanner adapted to receive identifying information corresponding to the filled prescription, a data storage device coupled to the scanner and adapted to store the identifying information corresponding to the filled prescription, wherein the data storage device comprises a plurality of data items, each of the plurality of data items corresponding to a known prescription pharmaceutical spectral signature.
In another aspect, a method of filling a prescription, comprises receiving a prescription request, entering the prescription request into an information system, dispensing the prescription from a supply source into a customer container, applying an identification label on the customer container, wherein the identification label contains identifying information corresponding to the prescription, storing the identifying information corresponding to the prescription, determining the identity of the prescription, and comparing the identity of the prescription to the identifying information.
As will become apparent to those skilled in the art, numerous other embodiments and aspects will become evident hereinafter from the following descriptions and claims.
BRIEF DESCRIPTION OF THE DRAWINGS
The drawings illustrate both the design and utility of the preferred embodiments of the present invention, wherein:
Figure 1 is a flow chart depicting a known pharmacy filling and verification process;
Figure 2 is a flow chart showing a pharmacy filling and verification process in accordance with an aspect of the present invention;
Figure 3 is a detailed flow chart of the chemical verification process in accordance with an aspect of the present invention;
Figure 4 is an embodiment of a chemical analysis and verification system in accordance with an aspect of the present invention;
Figure 5 is a detailed diagram of the main housing of a chemical analysis and verification system in accordance with an aspect of the present invention;
Figure 6 is a detailed diagram of the spectrometer and telescope assembly of a chemical analysis and verification system in accordance with an aspect of the present invention; and Figure 7 is a top view of a filled prescription vial as it is seen by a chemical analysis and verification system in accordance with an aspect of the present invention:
DETAILED DESCRIPTION
Approximately 90% of the most commonly prescribed and dispensed solid-dosage pharmaceuticals can be identified through an NIR or other spectroscopic technique with 100% accuracy. By comparing the "chemical signature" of a dispensed or filled prescription to an electronic database of known formulations, there can be near 100% assurance that a dispensed drug is correct in both type and concentration.
Figure 1 shows a workflow and validation process 100 that is typical for known pharmacies and their associated prescription filling procedures. While this example is based on the filling of a solid dosage prescription, similar procedures are utilized for other dosage forms. In the workflow 100 shown in Figure 1, 100% of the drugs stocked by a pharmacy and filled for a patient follow the same path. In the flow diagram 100, the bracketed text to the left indicates the pharmacy personnel that would typically perform the corresponding task. To begin the prescription filling process, a customer drops off or calls in an order at 110. The order consists of one or more new or refill prescriptions. The prescriptions) are entered into the pharmacy's information system at 120. As indicated, step 120 is typically performed by a technician or other administrative staff, although it may be performed by a pharmacist as well.
After the order has been entered into the pharmacy information system, a pharmacist verifies that the prescription has been entered into the pharmacy information system correctly at 130. Step 130 is typically performed by comparing the information entered into the pharmacy information system with the information contained on the written prescription. Some systems actually scan the written prescription into the pharmacy information systems so that a side by side comparison can be made on a computer screen of an image of the written prescription prepared by a physician and the data entered by the technician at step 120. Once the entered prescription is verified at 130, the filling process begins. A technician fills the prescription at 140. Some known systems utilize bar codes to ensure that the correct supply bottle has been selected by the technician. All manufacturer supply bottles include a bar coded identification number that contains information unique to the product and manufacturer. Other tasks that are typically performed at step 140 include assigning a tote (customer container to hold multiple prescriptions for the same customer) to the order, scanning the supply bottle, counting tablets and filling the vials, printing labels and applying the label to the vial, and closing the vial and placing it in the assigned tote. Further details of these visual pharmacy inspection and verification systems can be found in U.S.
Patent Nos.
5,597,995, 6,176,392, and 6,202,923, the details of which are hereby incorporated by reference into the present application.
After the order has been filed at 140, the pharmacist must verify the contents and accuracy of the filled order at 150. Since the pharmacist is ultimately responsible for the accuracy,of the filled order, this task is usually not assigned to a technician or other clerical employee. While the verification step 150 can be performed in several different ways, all existing pharmacy systems utilize a visual verification process that is carried out by a professional pharmacist. Figure 1 includes several examples (150-1, 150-2, and 150-3) of how this visual verification process is normally handled.
At 150-1 a pharmacist compares the contents of the filled customer vial with the supply bottle that was used to fill the prescription. In the case of 150-1, the supply bottle is often left in the customer tote with the filled vial for the pharmacist to use in verifying the vial's contents. This is, in effect, a tablet-to-tablet comparison.
Alternately, at 150-2 the pharmacist compares the contents of the filled vial to an image of the prescribed drug that is retrieved from a database displayed on a computer monitor for the pharmacist to view. This is a tablet-to-image comparison.
Alternately, at 150-3 the pharmacist compares an electronic image taken of the filled vials with a database image of the same prescribed drug. This is an image-to-image comparison.
Certain automated prescription filling systems utilize these image-based verification schemes by taking an image of the filled vial before it is released to the pharmacist for verification. Finally, at 160 the order is placed with the appropriate paperwork in a pickup area for the customer to receive the prescription.
As explained above, these known pharmacy systems all suffer from the same general problems in that they rely on a visual verification performed by a human operator to validate that the prescription has been properly filled. The result is that a significant number of prescriptions are incorrectly filled. Additionally, the pharmacist, who is ultimately responsible for the accuracy of the filled prescription, spends a significant portion of his or her day performing these verifications. These and other known pharmacy inspection systems are more fully described in U.S. Patent Nos.
5,597,995, 6,176,392, and 6,202,923, the details of which have previously been incorporated by reference into the present application.
In accordance with an aspect of the present invention, an inspection system is provided that preferably replaces the visual verification steps associated with traditional and known pharmacy systems. Alternatively, an inspection system constructed in accordance with the present invention can augment existing visual verification systems.
In addition, an inspection system constructed in accordance with the present invention can preferably be adapted for use with an existing pharmacy information system, or can be utilized as a stand alone and portable unit.
Figure 2 illustrates a work flow 200 associated with one aspect of a pharmacy inspection and validation system constructed in accordance with the present invention.
While this example is based on the filling of a solid dosage prescription, similar procedures may be utilized for other dosage forms. A customer drops off or otherwise communicates a prescription to the pharmacy at 210. At 220, the customer's prescription is input into the pharmacy's information system or, if the prescription is for a refill, the prescription is recalled from the pharmacy's information system.
Step 220, as in the system of Figure l, is typically performed by a pharmacy technician, rather than by a licensed pharmacist. At 230, a pharmacist performs a verification that the customer prescription is properly entered into the pharmacy information system. Step 230 is typically performed by comparing the information entered into the pharmacy information system with the information contained on the written prescription.
As in the system of Figure 1, some systems actually scan the written prescription into the pharmacy information system so that a side by side comparison can be made on a computer screen of an image of the written prescription prepared by a physician and the data entered by the technician at step 220. At 240, after the entered prescription is verified by the pharmacist, it is released for filling (typically done by a technician).
The technician then fills the customer vial and applies the prescription label, including a bar code linked to both the prescription number and the dispensed drug's unique NDC
code, to the vial. Preferably, the bar code on the prescription label includes a prescription number that is unique to that specific prescription fill. For example, a refill prescription will get a new prescription number and not one identical to the original prescription. This accounts for the situation where two prescriptions for the same drug are being filled at the same time and allows a unique identifier to be associated with the prescription in addition to the manufacturer's NDC code.
At this point, the filled vial is inserted into a chemical analysis system.
The chemical analysis and validation system is referred to herein as the RxSpecTM
system.
At 245, the bar code label on the filled customer prescription vial is read into the RxSpecTM system. The steps performed by the RxSpecTM system, and in general, the pharmacy chemical analysis and validation system, are generally shown in Figure 2 within the dashed lines represented by reference number 300. Preferably, the RxSpecTM system utilizes visible (Vis) and near-infrared (NIR) spectroscopy to analyze and identify the contents of the filled prescription vial, however, it is contemplated that any number of other methods or variations of NIR spectroscopy can be utilized in a pharmacy system constructed in accordance with the present invention. For example, various forms of optical spectroscopy, ultra-violet & visible (UV-Vis), Ultra-violet/visible/near infrared (UV-Vis-NIR), infrared, or Raman spectroscopy may be utilized in a chemical analysis and verification system constructed in accordance with the present invention. Additionally, optical imaging technology can also be integrated into a chemical analysis and verification system constructed in accordance with the present invention, such as systems that are adapted to perform optical character recognition (OCR), color analysis, or other physical (rather than chemical) property analysis and identification.
At 310, the RxSpecTM system compares the NDC derived from the bar code scanned from the label on the customer prescription vial, to a database of drugs that the RxSpecTM has been formatted or otherwise calibrated to chemically identify. At this point, no chemical identification has taken place, rather the RxSpecTM system is comparing the name and dosage of the drug associated with the customer's prescription with a preloaded database of drugs that the RxSpecTM system has been calibrated to analyze. The database also contains a representation of the unique chemical signatures associated with each of these calibrated drugs. It is contemplated that this database of calibrated drugs will be periodically updated to reflect new drugs that come on the market as well as existing drugs that are calibrated to be recognized by the RxSpecTM
system. If the customer's prescription is contained in the RxSpecTM database, then, at 320, the RxSpecTM system performs a chemical identification on the actual tablets, or capsules that are contained in the customer's prescription vial. At 320 the RxSpecTM
system scans the items in the filled vial and measures the chemical signature of the items. This actual chemical signature is then matched to a particular drug and dosage level from the database of calibrated drugs. This information is then compared at 330 to the prescription information taken from the bar code label on the customer's filled prescription vial, which has been previously stored by the RxSpecTM system. If the results from the RxSpecTM system match the information from the bar code on the customer's filled prescription vial, the RxSpecTM system signals that the filled prescription has been verified and the technician then closes the filled vial, finalizes the prescription, and places it into a tote for customer pickup at 340. The inspection and validation steps associated with the RxSpecTM system are automatic and can therefore be easily performed by a technician rather than a pharmacist.
If at step 310 it is determined that the customer's prescription is not contained in the RxSpecTM database, and therefore not amenable to chemical verification, the RxSpecTM system signals the technician that it can not chemically verify the customer's prescription and that another form of verification is necessary. At 350, an alternate verification means is then employed, such as one of the visual verification techniques previously described in connection with Figure 1. After the customer's filled prescription has been verified the prescription is finalized, bagged, and placed in a tote for customer pickup at 360.
From experimental results, it has been determined that in the process flow of Figure 2, approximately 90% of the drugs will be able to be recognized by the RxSpecTM system and will therefore be able to be automatically verified and validated by chemical analysis and comparison to the prescription's bar code information. Those drugs that are not recognized by the RxSpecTM system will need to be visually verified as described above or by a similar method. In practice, verifying a prescription using the RxSpecTM system is approximately 5 times faster than using a manual verification method, such as visual verification. For example, in efficiently run pharmacies, it takes approximately 25 seconds to visually verify a prescription. Using the RxSpecTM
system has been demonstrated to take approximately 5 seconds. Furthermore, the RxSpecTM system can be run by a technician since the verification process is entirely automatic. Visual verifications, since they are subject to user error, are typically performed by a pharmacist. Large retail pharmacies filling as many as 300 prescription per day and utilizing a verification system constructed in accordance with the present invention will realize a net result of the pharmacist having approximately 1.7 hours of available time to perform other tasks such as patient consultation or filling additional prescriptions. The RxSpecTM system directly identifies the actual drug contained in the prescription vial and compares it to a pre-stored library of drug signature data. For those drugs that are recognized by the RxSpecTM system, this verification is accomplished with virtually 100% accuracy. Other benefits are also realized by implementing the inspection and validation process of Figure 2. For instance, pharmacist job satisfaction and morale will likely increase as a result of reduced stress and less time performing visual verification tasks; there will be faster prescription throughput time for those drugs verified by the RxSpecTM system; there is a reduction in overtime wages; and the use of such an automated verification systems may be recognized as evidence of proper prescription filling in the context of litigation.
Figure 3 shows a detailed flow diagram 400 of a portion of the RxSpecTM
system, and more particularly, one embodiment of the automated chemical identification and verification process. At 410, a technician scans the bar code on a prescription vial's label using a scanner attached to the RxSpecTM system.
Preferably, the scanner presents an audible tone or visual indicator letting the user know that the label has been scanned successfully. The data obtained from the bar code is sent to and stored on a data storage device such as a magnetic disk drive or a network server. It is contemplated that various computer hardware platforms may be utilized in such a system such as PCDOS, WINDOWS, UNIX, LINUX, etc. Additionally, the hardware platform may be part of the pharmacy's existing information system.
After the data from the bar code label has been stored, the RxSpecTM system determines at 420 whether the drug, as represented by the data from the scanned bar code label on the customer's prescription vial, is in the RxSpecTM data library, and thus recognized by the RxSpecTM system. The RxSpecTM data library, is preferably a stored database of drug formulations, dosage signatures, and their associated product names, manufacturers and other identifying information that is recognized by and calibrated to the RxSpecTM system. If the drug in the filled prescription vial is not recognized by the RxSpecTM system, then at 430, the data server sends a message to the RxSpecTM
system and the technician is notified not to proceed with a chemical scan of the filled prescription through the RxSpecTM system. The technician and the general pharmacy information system are notified that this particular drug must follow a standard manual/visual verification routine as previously described in conjunction with Figure 1.
If the drug in the filled prescription vial is recognized by the RxSpecTM
system, then at 440, the RxSpecTM system indicates to the technician that he can proceed with the chemical scan. The technician then places the filled prescription vial into the RxSpecTM system, the drug, while still in the prescription vial, is scanned and the resulting chemical signature data is sent to the server or existing pharmacy information system. At 450, the RxSpecTM system compares the data obtained from the prescription vial bar code to the data obtained from the chemical scan and determines whether there is a match or whether there is some form of user error such as the prescription vial being improperly aligned in the RxSpecTM system. If there is a user error detected, the RxSpecTM system alerts the technician at 460 and allows the technician to rescan the drug. If the RxSpecTM system determines that the chemical scan of the drug and the data from the prescription vial bar code are a match, the RxSpecTM system at 470 sends a message to the technician that the drug has passed the chemical inspection and validation and that the prescription vial can be capped and the prescription completed. In this case, visual inspection is not necessary, although, if desired, the pharmacist can choose to also visually verify the filled prescription. If the RxSpecTM system determines that the chemical scan of the drug and the data from the prescription vial bar code are not a match, the RxSpecTM system at 480 sends a message to the technician that the drug has failed the chemical inspection and validation process.
A further message may also be sent to the technician indicating that either visual verification must be completed or that the pharmacist must otherwise intervene in the prescription filling process.
Figure 4 shows one embodiment of an RxSpecTM system 500 constructed in accordance with an aspect of the present invention. The RxSpecTM system 500 can be formatted to function either as a stand alone unit or to integrate into an existing pharmacy information system. Line 505 in Figure 4 defines an example of how the stand alone portion of the RxSpecTM system could be incorporated into an existing pharmacy information system. The portion above the line 505 would be located in the actual pharmacy within easy access of the pharmacist, while the portion below line 505 represents an existing pharmacy information system such as a network server or other information system platform. As a stand alone unit, the RxSpecTM system would preferably be linked to a PC based computer or portable computer system.
The RxSpecTM system 500 includes a main housing unit 510 that contains the chemical analysis hardware and associated electronics. Preferably, the chemical analysis hardware is an Vis-NIR-based spectrometer system adapted for use in the RxSpecTM system. However, other chemical analysis systems are contemplated by the present invention such as various forms of optical spectroscopy, ultra-violet & visible (UV-Vis), Ultra-violet/visible/near infrared (UV-Vis-N1R), infrared, or Raman spectroscopy. It is also envisioned that digital imagery could be used to automatically derive information on the size, shape, and color of solid dosage forms. The main housing 510 includes a local display unit 512 that provides a user with information such as pass/fail results, system status, power availability, and various other functional indicators of the RxSpecTM system 500. The main housing 510 is positioned on a mounting bracket 514 so that an imaging aperture or entrance slit 515 of the main housing faces a sample plate 516. The sample plate 516 is adapted to receive a sample, such as a prescription vial 532, so that the imaging aperture 515 substantially aligns with the vial 534. Preferably a guide 538 is incorporated into the sample plate 516 to easily and consistently align the vial 532 under the imaging aperture 515.
The main housing 510 is connected to a power source 519 through a cable 518 and connector 520. The main housing 510 of the RxSpecTM system preferably receives data through two separate connections. First, the main housing 510 receives data from data storage and analysis unit 550 through cable 522 and connector 524.
Second, the main housing 510 receives data from scanner 540 through cable 526 and connector 528.
The data storage and analysis unit, can, as described above, be either a network based system connected to the main housing 510 through a 10/100 Baser Ethernet connection, or it can be a local system, such as a PC or laptop computer connected through a serial or USB port. Various other connection schemes are also contemplated.
In operation, data obtained through the scanner 540 from a label 534 applied to the vial 532 is compared to data obtained by chemically identifying the actual product contained in the vial 532. Preferably the label 534 is a bar code containing the unique prescription number. In one embodiment a spectrometer-based system shines a light beam 536 at the product in the vial 532 and acquires the chemical signature data of the product. The chemical signature data and the data obtained from the bar code label 534 are both sent back to the data storage and analysis unit 550. The data storage and analysis unit 550 first queries the prescription database to determine the NDC
of the drug used to fill the prescription currently being verified. The data storage and analysis unit 550 preferably contains a database of chemical fingerprints corresponding to the drugs available in the pharmacy. The database also includes the corresponding NDC, manufacture name, drug name, and other identifying information about the available drugs. The data storage and analysis unit 550 is also adapted to run comparison software and other algorithms that automatically compare the NDC determined from the bar code label 534 and the signature of the analyzed product 534 contained in the vial 532. A message is sent from the data storage and analysis unit S50 back to the RxSpecTM system's main housing 510 alerting the user whether the prescription being verified has passed or failed the verification process.
The data storage and analysis unit 550 can take various forms as briefly described above. First, it can be part of an existing pharmacy information system, such as a UNIX based server where the RxSpecTM signature library and comparison software reside on a storage area within the existing server unit. Second, the data storage and analysis unit 550 can be a stand alone computer unit such as a PC based system or laptop computer system. In this case, the RxSpecTM chemical signature library and comparison software reside on a storage area within the stand alone unit. In that regard, the RxSpecTM system would be more conducive to portability and could be utilized in other sites than just pharmacies such as emergency rooms and ambulance environments.
Figure 5 shows a schematic detail of the housing 510 and, more particularly, one embodiment of its internal construction and interrelation between its various components. The housing 510 as shown in Figure 5, is configured for use with a spectrometer based analysis system, and more particularly, a Vis-NIR
spectrometer system, however, it is contemplated that other types of non-invasive chemical and/or physical analysis systems can be incorporated into systems constructed in accordance with the present invention and as described above. The housing 510 generally contains six main components or modules. An alphanumeric display 512, a main electronics board 600, a focal plane board 630, a spectrograph assembly 640, a light source 670 and a telescope 680. The arrows in Figure 5 show one embodiment of the inter-relationship between the different components of the main housing 510.
The alphanumeric display 510 is adapted to display a number of different information parameters pertaining to the status of the RxSpecTM system such as power on status, pass or fail results of an ongoing chemical screen or identification, etc. The main electronics board 600 includes the following modules and functions: a power supply 602, light regulation 604, data collection 606, microprocessor 608, ethernet interface 610, scanner or bar code interface 612, and a mechanism control 614.
The main electronics board 600 also preferably includes the connection ports for the power supply, the ethernet connection and a serial port for the scanner interface.
The focal plane board 630 includes the spectrometer detector and associated electronics 632. The detector 632 interprets the reflected light data from a sample being analyzed and transmits it back to the main electronics board for interpretation.
The detector and electronics 632 can be one of many known in the spectroscopy art. In other embodiments, the focal plane board may include an exit and~entrance slit for the spectrometer, a cut-on filter, a light source mirror, and mounts for each of the slits and filter.
The spectrograph assembly 640 includes a detector 642, grating 644, lens 646, encoder 648, motor 650, shutter 652, and scanner mechanism 654. The light source 670 is preferably a white light that provides a broad range of wavelengths and is adapted to illuminate a sample 700 that is being analyzed. The light source 670 may be integrated with the telescope assembly 680. The telescope assembly 680 includes slit imaging optics 682, a white reference mechanism 684, a beam rotate mechanism 686, and an auto-focus mechanism 688.
Figure 6 shows one embodiment of elements from the spectrograph assembly 640 and telescope 680 from Figure 5, and more particularly, the relationship between the telescope and focusing elements to the spectrometer. It is contemplated that numerous other embodiments of the spectrometer and telescope can be incorporated into a pharmacy inspection system in accordance with the present invention, many of which are known to those of skill in the art of spectroscopy and chemical analysis. In Figure 6, the combined spectrometer and telescope assembly includes a spectrometer 810 having an entrance slit 812, a pair of lenses 820 and 825, a collimated light source 830 a mirror 832, and a rotating beam steering element 840. The telescope assembly is generally referred to as 680. The dashed line 850 represents those elements of the telescope assembly that are adapted to move up and down in order to adjust the focal point of the system. Correct focus of the system is obtained by automatically adjusting the position of the telescope focusing elements 850 to a position that provides the maximum signal as measured by the spectrometer 810. The product being inspected 700 sits in the vial 532 and is positioned under the telescope assembly 680.
The rotating beam steering element 840 is adapted to take a series of measurements of the product 700. Preferably, the measurements are collected in a circular or ring shaped pattern to ensure consistency of the contents of the vial.
Figure 7 shows an image of the vial 532 filled with a product 700 that is being inspected. The image in Figure 7 is how the vial 532 and product 700 would appear to the telescope assembly, i.e. looking down into the filled vial. Ring 860 represents the scanning path produced by the rotating beam steering element 840 and points represent a series of locations measured by the RxSpecTM. Other sampling patterns or analysis algorithms may be incorporated into the spectrometer system in accordance with the present invention.
Although the present invention has been described and illustrated in the above description and drawings, it is understood that this description is by example only and that numerous changes and modifications can be made by those skilled in the art without departing from the true spirit and scope of the invention. The invention, therefore, is not to be restricted, except by the following claims and their equivalents.
Claims (54)
1. An apparatus for verifying the identity of a dispensed pharmaceutical, comprising:
an analysis unit adapted to determine a property of the dispensed pharmaceutical;
an input device adapted to receive predetermined identifying information corresponding to the dispensed pharmaceutical; and a comparison unit adapted to compare the determined property of the dispensed pharmaceutical with the predetermined identifying information.
an analysis unit adapted to determine a property of the dispensed pharmaceutical;
an input device adapted to receive predetermined identifying information corresponding to the dispensed pharmaceutical; and a comparison unit adapted to compare the determined property of the dispensed pharmaceutical with the predetermined identifying information.
2. The apparatus of claim 1, wherein the analysis unit is an optical spectroscopy system.
3. The apparatus of claim 1, wherein the analysis unit is a near-infrared optical spectroscopy system.
4. The apparatus if claim 1, wherein the analysis unit is a visible and near-infrared optical spectroscopy system.
5. The apparatus of claim 1, wherein the analysis unit is an infrared optical spectroscopy system.
6. The apparatus of claim 1, wherein the analysis unit is an ultra violet and visible spectroscopy system.
7. The apparatus of claim 1, wherein the analysis unit is an ultra violet, visible, and infrared spectroscopy system.
8. The apparatus of claim 1, wherein the analysis unit is a Raman spectroscopy system.
9. The apparatus of claim 1, wherein the analysis unit further comprises an imaging device adapted to determine a physical property of the dispensed pharmaceutical.
10. The apparatus of claim 9, wherein the physical property is size, shape, or color.
11. The apparatus of claim 9, wherein the imaging device is adapted to perform optical character recognition (OCR).
12. The apparatus of claim 1, wherein the analysis unit comprises a spectrometer.
13. The apparatus of claim 12, wherein the analysis unit further comprises a processor;
a telescope assembly coupled to the spectrometer; and a light source.
a telescope assembly coupled to the spectrometer; and a light source.
14. The apparatus of claim 1, wherein the input device is a scanner adapted to read a bar code symbol and wherein the predetermined identifying information corresponding to the dispensed pharmaceutical comprises a bar code symbol.
15. The apparatus of claim 1, wherein the predetermined identifying information corresponding to the dispensed pharmaceutical includes manufacturer information.
16. The apparatus of claim 1, wherein the predetermined identifying information corresponding to the dispensed pharmaceutical includes product name information.
17. The apparatus of claim 1, wherein the predetermined identifying information corresponding to the dispensed pharmaceutical includes dosage level information.
18. The apparatus of claim 1, wherein the predetermined identifying information corresponds to the same properties measured by the analysis unit.
19. The apparatus of claim 14, wherein the scanner is a hand-held device.
20. The apparatus of claim 14, wherein the scanner is a table top mounted device.
21. The apparatus of claim 1, wherein the comparison unit is integral with the analysis unit.
22. The apparatus of claim 1, wherein the apparatus is adapted for use in a retail pharmacy.
23. The apparatus of claim 1, wherein the apparatus is adapted for use in a central filling facility.
24. The apparatus of claim 1, wherein the apparatus is adapted for use in automated filling systems.
25. The apparatus of claim 1, wherein the apparatus is adapted for use as a stand alone unit.
26. The apparatus of claim 1, wherein the apparatus is adapted for integration with an existing pharmacy information system.
27. The apparatus of claim 1, wherein the dispensed pharmaceutical is a solid dosage pharmaceutical.
28. The apparatus of claim 1, wherein the dispensed pharmaceutical is a liquid pharmaceutical.
29. The apparatus of claim 1, further comprising a user interface.
30. The apparatus of claim 1, wherein the comparison unit comprises a microprocessor capable of being programmed with an algorithm.
31. The apparatus of claim 1, wherein the comparison unit comprises:
a network database adapted to store the predetermined identifying information corresponding to the dispensed pharmaceutical.
a network database adapted to store the predetermined identifying information corresponding to the dispensed pharmaceutical.
32. The apparatus of claim 1, wherein the apparatus is adapted to identify unknown drugs.
33. A method of verifying a prescription, wherein the prescription comprises a pharmaceutical compound, the method comprising:
associating the prescription with a unique identifier;
storing the unique identifier;
determining the identity of the pharmaceutical compound; and comparing the identity of the pharmaceutical compound with the unique identifier.
associating the prescription with a unique identifier;
storing the unique identifier;
determining the identity of the pharmaceutical compound; and comparing the identity of the pharmaceutical compound with the unique identifier.
34. The method of claim 33, further comprising:
associating the identity of the pharmaceutical compound with a unique chemical signature;
determining whether the chemical signature corresponds to the unique identifier;
displaying a first signal if the chemical signature corresponds to the unique identifier; and displaying a second signal if the chemical signature does not correspond to the unique identifier.
associating the identity of the pharmaceutical compound with a unique chemical signature;
determining whether the chemical signature corresponds to the unique identifier;
displaying a first signal if the chemical signature corresponds to the unique identifier; and displaying a second signal if the chemical signature does not correspond to the unique identifier.
35. The method of claim 33, wherein associating the prescription with a unique identifier comprises:
receiving the unique identifier from a pharmacy information system, wherein the unique identification number is in the form of a bar code; and associating the bar code with the prescription.
receiving the unique identifier from a pharmacy information system, wherein the unique identification number is in the form of a bar code; and associating the bar code with the prescription.
36. The method of claim 35, wherein storing the unique identifier comprises reading the bar code with a hand-held scanner.
37. The method of claim 33, wherein the unique identifier includes the manufacturer of the prescription pharmaceutical.
38. The method of claim 33, wherein the unique identifier includes the name and dosage level of the prescription pharmaceutical.
39. A method of adapting an existing pharmacy information system to perform verification of a dispensed pharmaceutical, comprising:
providing an analysis unit adapted to measure a property of the dispensed pharmaceutical;
providing an input device adapted to receive predetermined identifying information corresponding to the dispensed pharmaceutical; and providing a comparison unit adapted to compare the measured property of the dispensed pharmaceutical with the predetermined identifying information.
providing an analysis unit adapted to measure a property of the dispensed pharmaceutical;
providing an input device adapted to receive predetermined identifying information corresponding to the dispensed pharmaceutical; and providing a comparison unit adapted to compare the measured property of the dispensed pharmaceutical with the predetermined identifying information.
40. The method of claim 39, wherein the existing pharmacy information system includes a data storage device and wherein the comparison unit is incorporated into the data storage device.
41. The method of claim 39, wherein the existing pharmacy information system comprises an automated filling system.
42. The method of claim 39, wherein the existing pharmacy information system comprises a visual verification system.
43. The method of claim 39, wherein the analysis unit comprises a near-infrared spectroscopy system.
44. The method of claim 43, wherein the analysis unit further comprises an optical imaging system.
45. A inspection system for verifying the contents of a filled prescription, comprising:
a spectrometer adapted to determine the spectral signature of the contents of the filled prescription;
a scanner adapted to receive identifying information corresponding to the filled prescription;
a data storage device coupled to the scanner and adapted to store the identifying information corresponding to the filled prescription;
wherein the data storage device comprises a plurality of data items, each of the plurality of data items corresponding to a known prescription pharmaceutical spectral signature.
a spectrometer adapted to determine the spectral signature of the contents of the filled prescription;
a scanner adapted to receive identifying information corresponding to the filled prescription;
a data storage device coupled to the scanner and adapted to store the identifying information corresponding to the filled prescription;
wherein the data storage device comprises a plurality of data items, each of the plurality of data items corresponding to a known prescription pharmaceutical spectral signature.
46. The inspection system of claim 45, wherein the spectrometer operates in the ultra-violet, visible, and near infrared wavelengths.
47. The inspection system of claim 45, further comprising a telescope assembly coupled to the spectrometer.
48. The inspection system of claim 47, wherein the spectrometer is operative to focus the telescope assembly.
49. The inspection system of claim 47, wherein the telescope is adapted for confocal viewing and illumination.
50. The inspection system of claim 47, wherein the telescope further comprises a rotating beam steering element adapted to obtain multiple readings.
51. A method of filling a prescription, comprising:
receiving a prescription request;
entering the prescription request into an information system;
dispensing the prescription from a supply source into a customer container;
applying an identification label on the customer container, wherein the identification label contains identifying information corresponding to the prescription;
storing the identifying information corresponding to the prescription;
determining the identity of the prescription; and comparing the identity of the prescription to the identifying information.
receiving a prescription request;
entering the prescription request into an information system;
dispensing the prescription from a supply source into a customer container;
applying an identification label on the customer container, wherein the identification label contains identifying information corresponding to the prescription;
storing the identifying information corresponding to the prescription;
determining the identity of the prescription; and comparing the identity of the prescription to the identifying information.
52. The method of claim 51, wherein the method is implemented in a pharmacy.
53. The method of claim 51, wherein the method is implemented in an automated prescription filling station.
54. An apparatus for verifying the contents of a dispensed pharmaceutical, comprising:
means for determining information corresponding to a property of the dispensed pharmaceutical;
means for receiving predetermined identifying information corresponding to the dispensed pharmaceutical; and means for comparing the determined property of the dispensed pharmaceutical with the predetermined identifying information.
means for determining information corresponding to a property of the dispensed pharmaceutical;
means for receiving predetermined identifying information corresponding to the dispensed pharmaceutical; and means for comparing the determined property of the dispensed pharmaceutical with the predetermined identifying information.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/097,530 US6771369B2 (en) | 2002-03-12 | 2002-03-12 | System and method for pharmacy validation and inspection |
US10/097,530 | 2002-03-12 | ||
PCT/US2003/007365 WO2003079267A2 (en) | 2002-03-12 | 2003-03-11 | System and method for pharmacy validation and inspection |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2477259A1 true CA2477259A1 (en) | 2003-09-25 |
Family
ID=28039208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002477259A Abandoned CA2477259A1 (en) | 2002-03-12 | 2003-03-11 | System and method for pharmacy validation and inspection |
Country Status (5)
Country | Link |
---|---|
US (4) | US6771369B2 (en) |
EP (1) | EP1502223A2 (en) |
AU (1) | AU2003230624A1 (en) |
CA (1) | CA2477259A1 (en) |
WO (1) | WO2003079267A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9930297B2 (en) | 2010-04-30 | 2018-03-27 | Becton, Dickinson And Company | System and method for acquiring images of medication preparations |
US10417758B1 (en) | 2005-02-11 | 2019-09-17 | Becton, Dickinson And Company | System and method for remotely supervising and verifying pharmacy functions |
US10679342B2 (en) | 2014-09-08 | 2020-06-09 | Becton, Dickinson And Company | Aerodynamically streamlined enclosure for input devices of a medication preparation system |
Families Citing this family (188)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7925531B1 (en) * | 1995-11-13 | 2011-04-12 | TrialCard Incorporated | Method of delivering goods and services via media |
US7370797B1 (en) * | 1996-05-31 | 2008-05-13 | Scott Lindsay Sullivan | Pill printing and identification |
US7106826B2 (en) * | 2002-01-07 | 2006-09-12 | Cdex, Inc. | System and method for adapting a software control in an operating environment |
US6771369B2 (en) * | 2002-03-12 | 2004-08-03 | Analytical Spectral Devices, Inc. | System and method for pharmacy validation and inspection |
ATE356348T1 (en) * | 2002-07-22 | 2007-03-15 | Autom Partnership Cambridge | IR ANALYSIS SYSTEM |
US20040019794A1 (en) * | 2002-07-29 | 2004-01-29 | Ahmad Moradi | Method and system for delivering prescription medicine |
US7154102B2 (en) * | 2002-11-21 | 2006-12-26 | Cdex, Inc. | System and methods for detection and identification of chemical substances |
AU2003295774A1 (en) * | 2002-11-21 | 2004-06-18 | Cdex, Inc. | Methods and appartus for molecular species detection, inspection and classification using ultraviolet fluorescence |
US7753085B2 (en) | 2002-12-03 | 2010-07-13 | Forhealth Technologies, Inc. | Automated drug preparation apparatus including automated drug reconstitution |
US10688021B2 (en) | 2002-12-03 | 2020-06-23 | Baxter Corporation Englewood | Automated drug preparation apparatus including automated drug reconstitution |
US7995831B2 (en) * | 2003-01-30 | 2011-08-09 | Express Scripts, Inc. | Prescription bottle imaging system and method |
US20060015536A1 (en) * | 2003-02-10 | 2006-01-19 | Buchanan Bruce R | Database and method of use for authenticity verification of pharmaceuticals |
US20040227086A1 (en) * | 2003-03-07 | 2004-11-18 | Pfizer Inc | Method and device for NIR reflection spectroscopy |
US7218395B2 (en) * | 2003-04-16 | 2007-05-15 | Optopo Inc. | Rapid pharmaceutical identification and verification system |
US8731959B2 (en) * | 2003-04-16 | 2014-05-20 | Optopo Inc. | Spectroscopic chemical compound identification |
US7720694B2 (en) * | 2003-04-16 | 2010-05-18 | Optopo Inc. | Pharmaceutical verification network |
SE0301663D0 (en) * | 2003-06-10 | 2003-06-10 | Oncolog Medical Qa Ab | Method of analysis for infusion drugs |
US8831775B2 (en) * | 2003-07-02 | 2014-09-09 | Omnicare, Inc. | Method and system for electronic assistance in dispensing pharmaceuticals |
US20060283931A1 (en) * | 2003-09-22 | 2006-12-21 | University Of Maryland, Baltimore | Product authentication |
ATE551596T1 (en) * | 2003-09-22 | 2012-04-15 | Univ Maryland | MEDICINAL AUTHENTICATION |
US7028723B1 (en) * | 2003-11-03 | 2006-04-18 | Alouani Ali Tahar | Apparatus and method for automatic prescription verification |
US20060249423A1 (en) * | 2003-11-28 | 2006-11-09 | Mika Reijonen | Method and apparatus to identify and separate medicinal preparations and dosages thereof |
US7889346B2 (en) * | 2003-12-31 | 2011-02-15 | University Of South Carolina | Thin-layer porous optical sensors for gases and other fluids |
JP4482342B2 (en) * | 2004-01-30 | 2010-06-16 | 株式会社湯山製作所 | Tablet storage device |
US20100134794A1 (en) * | 2004-02-05 | 2010-06-03 | Medpro Holdings, Llc | Analyzer for determining the concentration, potency and purity of pharmaceutical compounds |
US7197405B1 (en) * | 2004-02-05 | 2007-03-27 | Medpro Holdings, Llc | Interactive method of providing analysis of potency and purity of pharmaceutical compounds |
US7660678B2 (en) * | 2004-02-05 | 2010-02-09 | Medpro Holdings, Llc | On-site method of providing analysis of potency and purity of pharmaceutical compounds |
US7602284B2 (en) * | 2004-03-04 | 2009-10-13 | Ethicon, Inc. | Sterilizer cassette handling system with data link |
US7548311B2 (en) * | 2005-04-29 | 2009-06-16 | Ahura Corporation | Method and apparatus for conducting Raman spectroscopy |
WO2006016913A2 (en) | 2004-04-30 | 2006-02-16 | Ahura Corporation | Method and apparatus for conducting raman spectroscopy |
US7799273B2 (en) * | 2004-05-06 | 2010-09-21 | Smp Logic Systems Llc | Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes |
US7444197B2 (en) | 2004-05-06 | 2008-10-28 | Smp Logic Systems Llc | Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes |
CA2567253A1 (en) * | 2004-05-18 | 2005-11-24 | Silverbrook Research Pty Ltd | Pharmaceutical product tracking |
US20050288906A1 (en) * | 2004-06-29 | 2005-12-29 | Drennen James K Iii | Spectroscopic pharmacy verification and inspection system |
WO2006025876A2 (en) * | 2004-08-30 | 2006-03-09 | Ahura Corporation | External cavity wavelength stabilized raman lasers insensitive to temperature and/or external mechanical stresses, and raman analyzer utilizing the same |
US7289208B2 (en) * | 2004-08-30 | 2007-10-30 | Ahura Corporation | Low profile spectrometer and Raman analyzer utilizing the same |
US20060088069A1 (en) * | 2004-08-30 | 2006-04-27 | Daryoosh Vakhshoori | Uncooled, low profile, external cavity wavelength stabilized laser, and portable Raman analyzer utilizing the same |
EP1789762A2 (en) * | 2004-08-30 | 2007-05-30 | Ahura Corporation | Use of free-space coupling between laser assembly, optical probe head assembly, spectrometer assembly and/or other optical elements for portable optical applications such as raman instruments |
US20070201136A1 (en) * | 2004-09-13 | 2007-08-30 | University Of South Carolina | Thin Film Interference Filter and Bootstrap Method for Interference Filter Thin Film Deposition Process Control |
US9141764B2 (en) | 2010-11-12 | 2015-09-22 | Edge Medical Properties, Llc | System and method for online integrated multiple tablet ordering |
US9245304B2 (en) * | 2004-10-01 | 2016-01-26 | Edge Medical Properties, Llc | Manufacturing separable pouches with a center cut blade |
US7690173B2 (en) * | 2005-09-30 | 2010-04-06 | Edge Medical, Inc. | Multiple prescription production facility |
US8266878B2 (en) * | 2004-10-01 | 2012-09-18 | Edge Medical Properties, Llc | System and method for verifying and assembling a multiple prescription package |
US9238518B2 (en) | 2004-10-01 | 2016-01-19 | Edge Medical Properties, Llc | Inspection system and method with a control process that inspects different medications |
US9015058B2 (en) | 2004-10-01 | 2015-04-21 | Edge Medical Properties, Llc | Matrix based dosage scheduling |
US9334096B2 (en) | 2004-10-01 | 2016-05-10 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US8914298B1 (en) | 2004-10-01 | 2014-12-16 | Edge Medical Properties, Llc | System and method for integrated verification and assembly of multi-script pouches into a housing container |
US8123036B2 (en) | 2004-10-01 | 2012-02-28 | Edge Medical Properties, Llc | Pill assembly for pill packaging and delivery systems |
US8146747B2 (en) * | 2004-10-01 | 2012-04-03 | Edge Medical Properties, Llc | Tablet dispensing container |
US9710866B2 (en) * | 2005-09-30 | 2017-07-18 | Edge Medical, Llc | System and method for processing a multiple prescription order |
US8712582B1 (en) | 2004-10-01 | 2014-04-29 | Edge Medical Properties, Llc | System and method for combining different tablets into a pouch |
US10315450B1 (en) | 2006-10-24 | 2019-06-11 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
US8972288B2 (en) | 2004-10-01 | 2015-03-03 | Edge Medical Properties, Llc | System and method for online matrix-based dosage scheduling |
US8789700B2 (en) * | 2004-10-01 | 2014-07-29 | Edge Medical Properties, Llc | System and method for communicating and inspecting a multiple tablet order |
US20110101016A1 (en) * | 2009-09-25 | 2011-05-05 | Edge Medical Properties, Llc | Low vision patient compliant medication management system and method |
US10836197B2 (en) | 2004-10-01 | 2020-11-17 | Edge Medical Properties, Llc | System and method for generating an integrated label for container housing multi-script pouches |
US7930064B2 (en) * | 2004-11-19 | 2011-04-19 | Parata Systems, Llc | Automated drug discrimination during dispensing |
KR100601118B1 (en) * | 2004-12-17 | 2006-07-19 | 한국전자통신연구원 | A Wireless Resource Allocation System and Method for Packet Data Service |
US8417540B2 (en) * | 2005-01-19 | 2013-04-09 | Optopo Inc. | Spectral signature extraction for drug verification and identification |
CN1696660A (en) * | 2005-04-05 | 2005-11-16 | 中国药品生物制品检定所 | Method and equipment for identifying medication by using near infrared spectral analysis |
US20060253346A1 (en) * | 2005-04-12 | 2006-11-09 | Gomez Michael R | Method and apparatus for bar code driven drug product verification with equivalency links |
US7599516B2 (en) | 2005-08-23 | 2009-10-06 | Illinois Tool Works Inc. | Machine vision counting system apparatus and method |
US20070189597A1 (en) * | 2005-08-23 | 2007-08-16 | Limer Daniel J | Machine vision counting system apparatus and method |
US8331678B2 (en) * | 2005-10-12 | 2012-12-11 | Optopo Inc. | Systems and methods for identifying a discontinuity in the boundary of an object in an image |
US7773645B2 (en) * | 2005-11-08 | 2010-08-10 | Ahura Scientific Inc. | Uncooled external cavity laser operating over an extended temperature range |
WO2007061435A1 (en) * | 2005-11-28 | 2007-05-31 | University Of South Carolina | Method of high-speed monitoring based on the use of multivariate optical elements |
WO2007061436A1 (en) | 2005-11-28 | 2007-05-31 | University Of South Carolina | Self calibration methods for optical analysis system |
EP1969326B1 (en) | 2005-11-28 | 2020-06-10 | Ometric Corporation | Optical analysis system and method for real time multivariate optical computing |
US20070166245A1 (en) * | 2005-11-28 | 2007-07-19 | Leonard Mackles | Propellant free foamable toothpaste composition |
EP1965988A4 (en) * | 2005-12-29 | 2011-08-10 | Chemimage Corp | Method and apparatus for counterfeiting protection |
WO2007078936A2 (en) * | 2005-12-29 | 2007-07-12 | Chemimage Corporation | Method and apparatus for counterfeiting protection |
EP1965987A4 (en) * | 2005-12-29 | 2011-04-20 | Chemimage Corp | Method and apparatus for counterfeiting protection |
EP1965984A2 (en) * | 2005-12-29 | 2008-09-10 | Chemimage Corporation | Method and apparatus for counterfeiting protection |
EP1965989A4 (en) * | 2005-12-29 | 2010-09-22 | Chemimage Corp | Method and apparatus for counterfeiting protection |
US8666760B2 (en) * | 2005-12-30 | 2014-03-04 | Carefusion 303, Inc. | Medication order processing and reconciliation |
US20070214014A1 (en) * | 2006-03-03 | 2007-09-13 | Suwalski Michael W | Pharmacy quality checking and alert system and method |
US7924414B2 (en) * | 2006-05-10 | 2011-04-12 | Abb Schweiz Ag | Non-hazardous bulk material analyzer system |
EP1862795A1 (en) * | 2006-05-10 | 2007-12-05 | ABB Schweiz AG | Bulk Material Analyzer System |
US9386327B2 (en) * | 2006-05-24 | 2016-07-05 | Time Warner Cable Enterprises Llc | Secondary content insertion apparatus and methods |
US8280982B2 (en) | 2006-05-24 | 2012-10-02 | Time Warner Cable Inc. | Personal content server apparatus and methods |
US8024762B2 (en) | 2006-06-13 | 2011-09-20 | Time Warner Cable Inc. | Methods and apparatus for providing virtual content over a network |
US20070294094A1 (en) * | 2006-06-20 | 2007-12-20 | Ometric Corporation | Methods of customizing, licensing and sustaining a technology option to meet a customer requirement |
EP2033196A2 (en) | 2006-06-26 | 2009-03-11 | University of South Carolina | Data validation and classification in optical analysis systems |
US8727208B2 (en) * | 2006-06-30 | 2014-05-20 | Intel-Ge Care Innovations Llc | Method for identifying pills via an optical device |
US7381972B1 (en) | 2006-07-24 | 2008-06-03 | Science Applications International Corporation | System and method for light fluorescence detection |
US7597247B2 (en) * | 2006-09-29 | 2009-10-06 | Global Healthcare Exchange, Llc | System and method for comparing drug product information |
US9182282B2 (en) | 2006-11-02 | 2015-11-10 | Halliburton Energy Services, Inc. | Multi-analyte optical computing system |
WO2008088729A1 (en) * | 2007-01-12 | 2008-07-24 | Parata Systems, Llc | System and method for verifying the contents of a filled, capped pharmaceutical prescription |
US20080177568A1 (en) * | 2007-01-24 | 2008-07-24 | Axsun Technologies, Inc. | Method and System for Pay-Per-Use Prescription Validation |
US8181206B2 (en) | 2007-02-28 | 2012-05-15 | Time Warner Cable Inc. | Personal content server apparatus and methods |
US7680553B2 (en) * | 2007-03-08 | 2010-03-16 | Smp Logic Systems Llc | Methods of interfacing nanomaterials for the monitoring and execution of pharmaceutical manufacturing processes |
WO2008121692A1 (en) | 2007-03-30 | 2008-10-09 | University Of South Carolina | Tablet analysis and measurement system |
US8213006B2 (en) * | 2007-03-30 | 2012-07-03 | Halliburton Energy Services, Inc. | Multi-analyte optical computing system |
US8212216B2 (en) | 2007-03-30 | 2012-07-03 | Halliburton Energy Services, Inc. | In-line process measurement systems and methods |
US20080306761A1 (en) * | 2007-06-07 | 2008-12-11 | Walgreen Co. | System and Method of Performing Remote Verification of a Prescription in Combination with a Patient Access Terminal |
US8775198B2 (en) * | 2007-07-25 | 2014-07-08 | Walgreen Co. | System and method for performing a remote verification of a pharmacy fill utilizing an image to image comparison |
IL185130A0 (en) | 2007-08-08 | 2008-01-06 | Semi Conductor Devices An Elbi | Thermal based system and method for detecting counterfeit drugs |
US8125637B2 (en) | 2007-11-09 | 2012-02-28 | Intevac, Inc. | Optical beam spectrometer with movable lens |
US8914148B2 (en) * | 2007-11-26 | 2014-12-16 | Micro Datastat, Ltd. | Pharmacy medication verification system |
US8283633B2 (en) * | 2007-11-30 | 2012-10-09 | Halliburton Energy Services, Inc. | Tuning D* with modified thermal detectors |
US8756230B2 (en) * | 2007-12-31 | 2014-06-17 | Atco Industries, Inc. | Quality validation method |
US7663108B2 (en) * | 2008-01-23 | 2010-02-16 | Abb Schweiz Ag | Pulverized bulk material planetary and double helix analyzer system |
US20090223990A1 (en) * | 2008-02-04 | 2009-09-10 | Bailey Kenneth S | System for authenticating prescriptive drugs at the time of dispensing |
US8728025B2 (en) * | 2008-03-10 | 2014-05-20 | S.E.A. Medical Systems, Inc. | Intravenous fluid monitoring |
US8212213B2 (en) | 2008-04-07 | 2012-07-03 | Halliburton Energy Services, Inc. | Chemically-selective detector and methods relating thereto |
US9280863B2 (en) | 2008-07-16 | 2016-03-08 | Parata Systems, Llc | Automated dispensing system for pharmaceuticals and other medical items |
WO2010011833A1 (en) * | 2008-07-23 | 2010-01-28 | Alexander Stuck | Secure tracking of tablets |
US8626672B2 (en) * | 2008-07-23 | 2014-01-07 | I-Property Holding Corp. | Secure tracking of tablets |
US20100068235A1 (en) * | 2008-09-16 | 2010-03-18 | Searete LLC, a limited liability corporation of Deleware | Individualizable dosage form |
US20100068233A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Modifiable dosage form |
US20100068275A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Personalizable dosage form |
US20100069887A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Multiple chamber ex vivo adjustable-release final dosage form |
US20100068256A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo modifiable medicament release-substance |
US20100069821A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo modifiable medicament release-sites final dosage form |
US20100068152A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo modifiable particle or polymeric based final dosage form |
US20100068153A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo activatable final dosage form |
US20100068254A1 (en) * | 2008-09-16 | 2010-03-18 | Mahalaxmi Gita Bangera | Modifying a medicament availability state of a final dosage form |
JP5207462B2 (en) * | 2008-10-06 | 2013-06-12 | 国立大学法人大阪大学 | Liquid inspection method and liquid inspection apparatus |
US7889330B2 (en) * | 2008-10-10 | 2011-02-15 | Parata Systems, Llc | Method of taking an image of an object residing in a transparent, colored container |
US8554579B2 (en) | 2008-10-13 | 2013-10-08 | Fht, Inc. | Management, reporting and benchmarking of medication preparation |
US8284386B2 (en) * | 2008-11-26 | 2012-10-09 | Parata Systems, Llc | System and method for verifying the contents of a filled, capped pharmaceutical prescription |
US8374965B2 (en) * | 2008-11-26 | 2013-02-12 | Parata Systems, Llc | System and method for verifying the contents of a filled, capped pharmaceutical prescription |
CN102378912A (en) | 2009-02-05 | 2012-03-14 | D.I.R.技术(红外检测)有限公司 | Method and system for determining the quality of pharmaceutical products |
US8345989B1 (en) | 2009-02-16 | 2013-01-01 | Parata Systems, Llc | Illumination station for use in pharmaceutical identification system and methods therefor |
WO2010120555A2 (en) * | 2009-03-31 | 2010-10-21 | The U.S.A, As Represented By The Secretary,Dpt. Of Health & Human Services | Device and method for detection of counterfeit pharmaceuticals and/or drug packaging |
US9052276B2 (en) | 2009-06-08 | 2015-06-09 | S.E.A. Medical Systems, Inc. | Systems and methods for the identification of compounds using admittance spectroscopy |
EP2545851A3 (en) * | 2009-06-08 | 2013-05-08 | S.E.A. Medical Systems, Inc. | Systems and methods for the identification of compounds in medical fluids using admittance spectroscopy |
US9189728B2 (en) * | 2009-07-23 | 2015-11-17 | I-Property Holding Corp. | Method for the authentication of dosage forms |
DE202009012784U1 (en) * | 2009-09-23 | 2011-02-10 | Steinweg, Detlef | Device for controlling the content of packaging units containing medicaments |
US8537004B2 (en) * | 2009-09-30 | 2013-09-17 | Carefusion 303, Inc. | Verification of dispensed items |
US8394053B2 (en) * | 2009-11-06 | 2013-03-12 | Crisi Medical Systems, Inc. | Medication injection site and data collection system |
US8190481B2 (en) * | 2009-12-15 | 2012-05-29 | Target Brands, Inc. | Anonymous pharmacy order processing |
US8477989B2 (en) * | 2010-01-14 | 2013-07-02 | Parata Systems, Llc | Method of taking an image of an object residing in a transparent, colored container |
CA2791818C (en) | 2010-03-05 | 2014-04-08 | Frederic Poirier | Verification system for prescription packaging and method |
WO2011112606A1 (en) | 2010-03-09 | 2011-09-15 | Perceptimed, Inc. | Medication verification and dispensing |
US8702674B2 (en) | 2010-04-27 | 2014-04-22 | Crisi Medical Systems, Inc. | Medication and identification information transfer apparatus |
US9101534B2 (en) | 2010-04-27 | 2015-08-11 | Crisi Medical Systems, Inc. | Medication and identification information transfer apparatus |
US8328082B1 (en) * | 2010-05-30 | 2012-12-11 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
US10492991B2 (en) | 2010-05-30 | 2019-12-03 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
US9514131B1 (en) * | 2010-05-30 | 2016-12-06 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
EP2580688A4 (en) | 2010-06-14 | 2017-05-10 | Trutag Technologies, Inc. | Labeling and verifying an item with an identifier |
EP2580687A4 (en) * | 2010-06-14 | 2014-04-30 | Trutag Technologies Inc | System for verifying an item in a package using a database |
SG186282A1 (en) * | 2010-06-14 | 2013-01-30 | Trutag Technologies Inc | System for verifying an item in a package |
US8606596B1 (en) | 2010-06-27 | 2013-12-10 | Crisi Medical Systems, Inc. | Medication waste and data collection system |
US8838395B2 (en) | 2010-09-09 | 2014-09-16 | S.E.A. Medical Systems, Inc. | Systems and methods for intravenous drug management using immittance spectroscopy |
EP2694933B1 (en) | 2011-04-06 | 2019-08-28 | Klein Medical Limited | Spectroscopic analyser |
US10435192B2 (en) | 2011-05-16 | 2019-10-08 | Edge Medical Properties, Llc | Multiple inspection system and method that inspects different medications |
US20130022250A1 (en) * | 2011-05-17 | 2013-01-24 | Gii Acquisition, Llc Dba General Inspection, Llc | Method and system for inspecting dosage forms having code imprints using chemical imaging and sorting the inspected dosage forms |
US9078809B2 (en) | 2011-06-16 | 2015-07-14 | Crisi Medical Systems, Inc. | Medication dose preparation and transfer system |
US10293107B2 (en) | 2011-06-22 | 2019-05-21 | Crisi Medical Systems, Inc. | Selectively Controlling fluid flow through a fluid pathway |
US9744298B2 (en) | 2011-06-22 | 2017-08-29 | Crisi Medical Systems, Inc. | Selectively controlling fluid flow through a fluid pathway |
US9073206B2 (en) | 2012-06-21 | 2015-07-07 | Omnicare, Inc. | Methods and apparatus for automated filling of packagings with medications |
WO2013009852A1 (en) | 2011-07-11 | 2013-01-17 | Omnicare, Inc. | Methods and apparatus for filling packagings with medications |
US8990099B2 (en) | 2011-08-02 | 2015-03-24 | Kit Check, Inc. | Management of pharmacy kits |
US9449296B2 (en) | 2011-08-02 | 2016-09-20 | Kit Check, Inc. | Management of pharmacy kits using multiple acceptance criteria for pharmacy kit segments |
US9697331B2 (en) * | 2011-11-01 | 2017-07-04 | Codonics, Inc. | Adaptable information extraction and labeling method and system |
JP5921025B2 (en) * | 2011-11-09 | 2016-05-24 | 株式会社タカゾノテクノロジー | Drug packaging device |
WO2013112591A1 (en) | 2012-01-23 | 2013-08-01 | Perceptimed, Inc. | Automated pharmaceutical pill identification |
US20130258341A1 (en) * | 2012-03-27 | 2013-10-03 | David R. Day | Sample Accessory for Handheld Spectrometers |
US11581079B1 (en) | 2012-04-10 | 2023-02-14 | Walgreen Co. | System and method for virtual review of a pharmaceutical product filling process |
EP2861968A4 (en) | 2012-06-19 | 2016-03-09 | Klein Medical Ltd | Spectroscopic analysis |
US20140114470A1 (en) * | 2012-10-24 | 2014-04-24 | Rashid Pharmacy, P.L.C. | Methods and systems for improving efficiency of pharmacy practice and reducing the incidence of medication errors |
CA2889352C (en) | 2012-10-26 | 2021-12-07 | Baxter Corporation Englewood | Improved work station for medical dose preparation system |
KR101974258B1 (en) | 2012-10-26 | 2019-04-30 | 백스터 코포레이션 잉글우드 | Improved image acquisition for medical dose preparation system |
WO2014089406A1 (en) * | 2012-12-07 | 2014-06-12 | The United States Of America, As Represented By The Secretary,Department Of Health & Human Services | Device and method for detection of counterfeit pharmaceuticals and/or drug packaging |
US8712163B1 (en) | 2012-12-14 | 2014-04-29 | EyeNode, LLC | Pill identification and counterfeit detection method |
US20140282786A1 (en) | 2013-03-12 | 2014-09-18 | Time Warner Cable Enterprises Llc | Methods and apparatus for providing and uploading content to personalized network storage |
US10143830B2 (en) | 2013-03-13 | 2018-12-04 | Crisi Medical Systems, Inc. | Injection site information cap |
US20140350945A1 (en) * | 2013-05-22 | 2014-11-27 | Professional Compounding Centers Of America | System and Method for Validation of Pharmaceutical Composition Formulations |
JP5975941B2 (en) * | 2013-06-21 | 2016-08-23 | 富士フイルム株式会社 | Packaged drug inspection device and method |
US10262114B2 (en) * | 2013-08-29 | 2019-04-16 | Aesynt Incorporated | Method, apparatus, and computer program product for the packaging and verification of medication information |
US9171280B2 (en) | 2013-12-08 | 2015-10-27 | Kit Check, Inc. | Medication tracking |
EP3826028A1 (en) | 2014-06-30 | 2021-05-26 | Baxter Corporation Englewood | Managed medical information exchange |
US20160019366A1 (en) * | 2014-07-17 | 2016-01-21 | Paul P. Klomp | Method for Validation of Pharmaceutical Composition Formulations |
GB2529724A (en) * | 2014-09-01 | 2016-03-02 | Promtek Ltd | Verification of material |
US11575673B2 (en) | 2014-09-30 | 2023-02-07 | Baxter Corporation Englewood | Central user management in a distributed healthcare information management system |
US11107574B2 (en) | 2014-09-30 | 2021-08-31 | Baxter Corporation Englewood | Management of medication preparation with formulary management |
US10331855B1 (en) | 2014-10-16 | 2019-06-25 | Walgreen Co. | Modular prescription approval system |
US10543152B1 (en) | 2014-10-22 | 2020-01-28 | Walgreen Co. | Method and apparatus for providing prescription verification |
AU2015338159B2 (en) * | 2014-10-31 | 2019-10-03 | Yuyama Mfg. Co., Ltd. | Drug dispensing device |
EP3937116A1 (en) | 2014-12-05 | 2022-01-12 | Baxter Corporation Englewood | Dose preparation data analytics |
WO2016122907A1 (en) * | 2015-01-15 | 2016-08-04 | Codonics, Inc. | Medical labeling apparatus with drug information |
WO2016143084A1 (en) * | 2015-03-11 | 2016-09-15 | 株式会社日立ハイテクノロジーズ | Optical measurement device and optical measurement method |
US9956145B2 (en) | 2015-09-23 | 2018-05-01 | Derek William THOMPSON | Visual counting system |
US10482292B2 (en) | 2016-10-03 | 2019-11-19 | Gary L. Sharpe | RFID scanning device |
US10692316B2 (en) | 2016-10-03 | 2020-06-23 | Gary L. Sharpe | RFID scanning device |
US20190088354A1 (en) | 2017-09-01 | 2019-03-21 | Kit Check, Inc. | Identifying discrepancies between events from disparate systems |
GB201814644D0 (en) * | 2018-09-10 | 2018-10-24 | Hilton Eric | Analysis and dispensing system |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4143770A (en) | 1976-06-23 | 1979-03-13 | Hoffmann-La Roche Inc. | Method and apparatus for color recognition and defect detection of objects such as capsules |
US4183013A (en) | 1976-11-29 | 1980-01-08 | Coulter Electronics, Inc. | System for extracting shape features from an image |
US4573606A (en) | 1983-09-12 | 1986-03-04 | Kermit E. Lewis | Automatic pill dispenser and method of administering medical pills |
US4953745A (en) * | 1983-09-19 | 1990-09-04 | James R. Rowlett, Jr. | Medication dispensing apparatus |
US4640560A (en) | 1984-12-17 | 1987-02-03 | Blum Richard S | Pill dispenser |
US4766551A (en) * | 1986-09-22 | 1988-08-23 | Pacific Scientific Company | Method of comparing spectra to identify similar materials |
US4991223A (en) | 1988-06-30 | 1991-02-05 | American Innovision, Inc. | Apparatus and method for recognizing image features using color elements |
US4918604A (en) | 1988-10-03 | 1990-04-17 | Medco Containment Services, Inc. | Prescription drug depiction and labeling system |
US5132126A (en) * | 1989-06-19 | 1992-07-21 | John Sinkler | Process for preparing a bacon product |
US5050991A (en) * | 1989-09-29 | 1991-09-24 | The United States Of America As Represented By The Secretary Of The Navy | High optical density measuring spectrometer |
IT1244884B (en) * | 1990-12-21 | 1994-09-13 | Healtech Sa | PROCEDURE AND EQUIPMENT FOR THE UNIQUE COMBINATION OF DRUGS CORRESPONDING TO A THERAPY PREDICTED TO A CERTAIN PATIENT |
US5441165A (en) | 1991-07-22 | 1995-08-15 | Kemp; Vivian | Autonomous controlled drug dispensing system |
DE4319878A1 (en) * | 1992-06-17 | 1993-12-23 | Micron Technology Inc | High frequency identification system card - has integrated circuit chip or carrier layer sealed by top layer and coupled to batteries and antenna system |
US5322813A (en) * | 1992-08-31 | 1994-06-21 | International Business Machines Corporation | Method of making supersaturated rare earth doped semiconductor layers by chemical vapor deposition |
US5337919A (en) | 1993-02-11 | 1994-08-16 | Dispensing Technologies, Inc. | Automatic dispensing system for prescriptions and the like |
FR2704650B1 (en) * | 1993-04-27 | 1995-06-09 | Savoie Universite | Method and device for instant detection and identification of an entity. |
US5502944A (en) | 1993-12-03 | 1996-04-02 | Owen Healthcare, Inc. | Medication dispenser system |
US5712658A (en) | 1993-12-28 | 1998-01-27 | Hitachi, Ltd. | Information presentation apparatus and information display apparatus |
WO1995024699A1 (en) | 1994-03-07 | 1995-09-14 | Pearson Walter G | Semi-automated medication dispenser |
US5522512A (en) | 1994-05-09 | 1996-06-04 | Merck & Co., Inc. | System and method for automatically feeding, inspecting and diverting tablets for continuous filling of tablet containers |
DE4417015A1 (en) * | 1994-05-14 | 1995-11-16 | Maschimpex Gmbh | Sorting machine for sorting or classifying small products of the pharmaceutical and confectionery industries by shape and color |
US5720154A (en) | 1994-05-27 | 1998-02-24 | Medco Containment Services, Inc. | Enhanced drug dispensing system |
US5660305A (en) | 1994-08-02 | 1997-08-26 | Medco Containment Services, Inc. | Automatic prescription dispensing system |
US5992742A (en) * | 1994-08-05 | 1999-11-30 | Sullivan; Scott L. | Pill printing and identification |
US5504332A (en) * | 1994-08-26 | 1996-04-02 | Merck & Co., Inc. | Method and system for determining the homogeneity of tablets |
US5900634A (en) | 1994-11-14 | 1999-05-04 | Soloman; Sabrie | Real-time on-line analysis of organic and non-organic compounds for food, fertilizers, and pharmaceutical products |
US5679954A (en) | 1994-11-14 | 1997-10-21 | Soloman; Sabrie | Non-destructive identification of tablet and tablet dissolution by means of infared spectroscopy |
US5623145A (en) | 1995-02-15 | 1997-04-22 | Lucent Technologies Inc. | Method and apparatus for terahertz imaging |
JP3476958B2 (en) * | 1995-04-12 | 2003-12-10 | アークレイ株式会社 | A method for stabilizing spectra in spectrometry. |
US5752234A (en) | 1995-08-18 | 1998-05-12 | Patient Solutions | Method and apparatus for managing disposable medical supplies appropriate for a single patient visit |
US5760399A (en) * | 1995-10-02 | 1998-06-02 | Foss Nirsystems, Inc. | Measurement of transmission spectra of pharmaceutical tablets |
US5597995A (en) | 1995-11-08 | 1997-01-28 | Automated Prescription Systems, Inc. | Automated medical prescription fulfillment system having work stations for imaging, filling, and checking the dispensed drug product |
US5628530A (en) * | 1995-12-12 | 1997-05-13 | Info Tec Llc | Method and system for collectively tracking demographics of starter drug samples |
US5845264A (en) * | 1996-03-07 | 1998-12-01 | Nellhaus; Gerhard | Bar code identification of drugs |
US5713487A (en) * | 1996-03-11 | 1998-02-03 | Scriptpro L.L.C. | Medicament verification in an automatic dispening system |
US5771657A (en) | 1996-05-07 | 1998-06-30 | Merck Medco Managed Care, Inc. | Automatic prescription filling, sorting and packaging system |
US5822219A (en) * | 1996-05-13 | 1998-10-13 | Foss Nirsystems, Inc. | System for identifying materials by NIR spectrometry |
EP1009359A1 (en) * | 1996-09-06 | 2000-06-21 | Merck & Co., Inc. | Customer specific packaging line |
US5939721A (en) | 1996-11-06 | 1999-08-17 | Lucent Technologies Inc. | Systems and methods for processing and analyzing terahertz waveforms |
US6021392A (en) | 1996-12-09 | 2000-02-01 | Pyxis Corporation | System and method for drug management |
US6535637B1 (en) | 1997-04-04 | 2003-03-18 | Esco Electronics, Inc. | Pharmaceutical pill recognition and verification system |
US5915560A (en) | 1997-05-03 | 1999-06-29 | George; Donald C. | Compartmentalized pill dispenser |
EP0887638B1 (en) | 1997-06-24 | 2003-05-07 | Uhlmann VisioTec GmbH | Apparatus and method for verifying product integrity |
KR20010023208A (en) * | 1997-08-28 | 2001-03-26 | 브루스, 제임스 에이취 | Chemical and Pharmacological Standardization of Herbal Extracts |
US6176392B1 (en) | 1997-12-05 | 2001-01-23 | Mckesson Automated Prescription Systems, Inc. | Pill dispensing system |
US6014631A (en) | 1998-04-02 | 2000-01-11 | Merck-Medco Managed Care, Llc | Computer implemented patient medication review system and process for the managed care, health care and/or pharmacy industry |
US6350369B1 (en) * | 1998-04-14 | 2002-02-26 | California Institute Of Technology | Method and system for determining analyte activity |
US6111639A (en) * | 1998-05-06 | 2000-08-29 | Reduto; Lawrence A. | Method and apparatus for countering adverse drug events |
US6307625B1 (en) * | 1998-06-29 | 2001-10-23 | San Diego State University | Method and apparatus for determination of carbon-halogen compounds and applications thereof |
AU5104399A (en) * | 1998-07-20 | 2000-02-07 | William Neil Jones | A method of individually tracking and identifying a drug delivery device |
US6170746B1 (en) * | 1998-08-12 | 2001-01-09 | Monarch Marking Systems, Inc. | System and method for tracking drugs in a hospital |
WO2000029829A1 (en) * | 1998-11-16 | 2000-05-25 | California Institute Of Technology | Simultaneous determination of equilibrium and kinetic properties |
US6490030B1 (en) * | 1999-01-18 | 2002-12-03 | Verification Technologies, Inc. | Portable product authentication device |
AU1429401A (en) * | 1999-07-02 | 2001-02-05 | Conceptual Mindworks, Inc. | Organic semiconductor recognition complex and system |
US6202923B1 (en) | 1999-08-23 | 2001-03-20 | Innovation Associates, Inc. | Automated pharmacy |
SE9903423D0 (en) * | 1999-09-22 | 1999-09-22 | Astra Ab | New measuring technique |
AU2001261311A1 (en) * | 2000-05-09 | 2001-11-20 | Pharmacia And Upjohn | Chemical structure identification |
US6680203B2 (en) * | 2000-07-10 | 2004-01-20 | Esperion Therapeutics, Inc. | Fourier transform mass spectrometry of complex biological samples |
WO2002007066A1 (en) * | 2000-07-14 | 2002-01-24 | Spectral Dimensions, Inc. | High-volume on-line spectroscopic composition testing of pharmaceutical dosage units |
US6853447B2 (en) * | 2001-02-12 | 2005-02-08 | Analytical Spectral Devices, Inc. | System and method for the collection of spectral image data |
US6894772B2 (en) * | 2001-02-12 | 2005-05-17 | Analytical Spectral Devices | System and method for grouping reflectance data |
US6765212B2 (en) * | 2001-02-12 | 2004-07-20 | Analytical Spectral Devices, Inc. | System and method for combining reflectance data |
US6667802B2 (en) * | 2001-02-12 | 2003-12-23 | Analytical Spectral Devices, Inc. | System and method for self-referencing calibration |
US6771369B2 (en) * | 2002-03-12 | 2004-08-03 | Analytical Spectral Devices, Inc. | System and method for pharmacy validation and inspection |
US7930064B2 (en) * | 2004-11-19 | 2011-04-19 | Parata Systems, Llc | Automated drug discrimination during dispensing |
-
2002
- 2002-03-12 US US10/097,530 patent/US6771369B2/en not_active Expired - Fee Related
-
2003
- 2003-03-11 WO PCT/US2003/007365 patent/WO2003079267A2/en not_active Application Discontinuation
- 2003-03-11 CA CA002477259A patent/CA2477259A1/en not_active Abandoned
- 2003-03-11 EP EP03723711A patent/EP1502223A2/en not_active Ceased
- 2003-03-11 AU AU2003230624A patent/AU2003230624A1/en not_active Abandoned
-
2004
- 2004-05-13 US US10/845,035 patent/US7006214B2/en not_active Expired - Lifetime
-
2005
- 2005-12-21 US US11/314,914 patent/US7317525B2/en not_active Expired - Fee Related
-
2007
- 2007-06-29 US US11/770,988 patent/US20100157293A9/en not_active Abandoned
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10417758B1 (en) | 2005-02-11 | 2019-09-17 | Becton, Dickinson And Company | System and method for remotely supervising and verifying pharmacy functions |
US11516443B2 (en) | 2010-04-30 | 2022-11-29 | Becton, Dickinson And Company | System and method for acquiring images of medication preparations |
US10412347B2 (en) | 2010-04-30 | 2019-09-10 | Becton, Dickinson And Company | System and method for acquiring images of medication preparation |
US10554937B2 (en) | 2010-04-30 | 2020-02-04 | Becton, Dickinson And Company | System and method for acquiring images of medication preparations |
US11064164B2 (en) | 2010-04-30 | 2021-07-13 | Becton, Dickinson And Company | System and method for acquiring images of medication preparations |
US9930297B2 (en) | 2010-04-30 | 2018-03-27 | Becton, Dickinson And Company | System and method for acquiring images of medication preparations |
US11838690B2 (en) | 2010-04-30 | 2023-12-05 | Becton, Dickinson And Company | System and method for acquiring images of medication preparations |
US10679342B2 (en) | 2014-09-08 | 2020-06-09 | Becton, Dickinson And Company | Aerodynamically streamlined enclosure for input devices of a medication preparation system |
US10692207B2 (en) | 2014-09-08 | 2020-06-23 | Becton, Dickinson And Company | System and method for preparing a pharmaceutical compound |
US10853938B2 (en) | 2014-09-08 | 2020-12-01 | Becton, Dickinson And Company | Enhanced platen for pharmaceutical compounding |
US11341641B2 (en) | 2014-09-08 | 2022-05-24 | Becton, Dickinson And Company | Aerodynamically streamlined enclosure for input devices of a medication preparation system |
US11568537B2 (en) | 2014-09-08 | 2023-01-31 | Becton, Dickinson And Company | Enhanced platen for pharmaceutical compounding |
US11763448B2 (en) | 2014-09-08 | 2023-09-19 | Becton, Dickinson And Company | System and method for preparing a pharmaceutical compound |
Also Published As
Publication number | Publication date |
---|---|
US6771369B2 (en) | 2004-08-03 |
US20040207842A1 (en) | 2004-10-21 |
EP1502223A2 (en) | 2005-02-02 |
WO2003079267A2 (en) | 2003-09-25 |
US20100157293A9 (en) | 2010-06-24 |
US20070279625A1 (en) | 2007-12-06 |
US20060098193A1 (en) | 2006-05-11 |
US7317525B2 (en) | 2008-01-08 |
US7006214B2 (en) | 2006-02-28 |
AU2003230624A8 (en) | 2003-09-29 |
AU2003230624A1 (en) | 2003-09-29 |
WO2003079267A3 (en) | 2004-12-02 |
US20030174326A1 (en) | 2003-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6771369B2 (en) | System and method for pharmacy validation and inspection | |
EP1938061B1 (en) | Rapid pharmaceutical identification and verification system | |
US8284386B2 (en) | System and method for verifying the contents of a filled, capped pharmaceutical prescription | |
US7898657B2 (en) | System and method for verifying the contents of a filled, capped pharmaceutical prescription | |
CA2579688C (en) | Automated drug discrimination during dispensing | |
US8670066B2 (en) | Method of acquiring an image in a transparent, colored container | |
US7990526B2 (en) | Method of taking an image of an object residing in a transparent, colored container | |
WO2006004656A2 (en) | Spectroscopic pharmacy verification and inspection system | |
US8477989B2 (en) | Method of taking an image of an object residing in a transparent, colored container | |
JP2020085513A (en) | Drug identifying device and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20110311 |